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Site Selection and Cellular
Delivery of Heterologous 
Proteins
Vesa Turkki
Lentiviral Integrase-fusions: Genomic 
Interactions, Site Selection and Cellular 
Delivery of Heterologous Proteins
In this study, a protein delivery 
method based on lentiviral 
integrase-fusions was characterized. 
Its applicability was demonstrated 
with a fluorescent marker protein 
to allow virus labeling, a tumour 
suppressor protein and a DNA-
cleaving meganuclease. Modified 
cleavage-deficient meganucleases 
were shown capable of directing 
the integration into genomic target 
areas. Furthermore, the interactions 
between the integrase and the host 

























































































































































transported into target cells,usuallybymeansofagenecarrier calledavector.Over the
years,aconsiderablenumberoftreatmentstrategiesandavarietyoftransgeneshavebeen
proposed foruse ingene therapyapplications.Unfortunately severalpromising concepts
havefailedduetothelackofsafeandefficientgenetransfervector.Lentiviralvectorsarea
feasible option, especially for therapies requiring longterm transgene expression. This is
due to thepermanent integrationof the transgene into thehost cell’s genome, a reaction




In this work a novel cispackaging strategy for heterologous protein incorporation into
thirdgeneration lentiviral vectors was characterized. The method relies on integrase
fusion, which was shown here to be tolerated in these vectors despite earlier negative
indications.PackagingoffusionproteinswasdemonstratedusingfluorescentmCherryand
tumour suppressorp53 as fusionpartners. In thepresent studies, vectors andviruslike




vectors. For targeted integration studies, an integrase fusion protein with a sequence
specific IPpoImeganucleasewasconstructedalongwith functionalmutants fordifferent
applications. The meganuclease, when stripped of its cutting capability, but without
interfering with DNArecognition, was shown to be able to enhance integration into its
natural targetareas in thegenome. Inorder to furthercharacterize theeffectsof IPpoI–
induced double strand breaks, several cell lines were studied. Variable responses were
observed in termsofcytotoxicity. Inparticular,cancercellsweresusceptible to treatment
andthisapparentcytotoxiceffectwaspreservedinaninvivotumourstudy.Thespecificity
ofIPpoIcleavagewasdemonstratedbychromatinimmunoprecipitationbasedstrategies,
where the sites of interactions between viral integrase and the host chromatin were
mapped.Also interesting resultswarranting future studieswereobtained in termsof the
interaction and integration patterns ofwildtype IN. In summary the results obtained in
this thesishighlight thebenefitsof thedirectcispackagingmethodandprovideproofof



























Geeniterapiassa potilaaseen siirretään uutta geneettistä materiaalia, jonka ilmentäminen
kudoksissa johtaa terapeuttiseenvaikutukseen.Geneettisenmateriaalinsiirtoonkäytetään
vektoreiksi kutsuttuja geenikuljettimia, jotka on usein muokattu virusten pohjalta.
Geeniterapiakokeita varten on tutkittu useita erilaisia siirtogeenejä, mutta monet
lupaavatkaanlähestymistavateivätoletuottaneettoivottuavaikutustataiovatjohtaneetei
toivottuun lopputulokseen optimaalisen vektorin puutteessa. Lentiviruksista voidaan
kehittää vektoreita erityisesti pitkäaikaista siirtogeenin ilmentymistä vaativiin
hoitomuotoihin. Lentivirusvektoreilla on kyky liittää, eli integroida, siirtogeeni kiinteäksi
osaksi kohdesolun genomia, saaden aikaan siten jopa pysyvän geenin ilmentymisen.
Geeninliittämisestägenomiinvastaavektorinintegraasiproteiini.Toinenlentivirussovellus
niin tutkimus kuin hoitokäyttöön on siirtää kohdesoluihin geenin sijasta suoraan sen
ilmentämääproteiinia(nk.proteiinitransduktio).

Työssä esiteltiin uusi suora pakkausmenetelmä vieraiden proteiinien liittämiseksi
kolmannen sukupolven lentivirusvektoreihin. Työssä osoitettiin, että aiemmista
negatiivista indikaatioista huolimatta kuljetettavat proteiinit voidaan fuusioida vektorin
integraasiin. Pakkausmenetelmän toimivuus osoitettiin sekä fluoresoivan mCherry että
tuumorien kasvua inhiboivan p53proteiinin avulla. Tuotetut vektorit sisälsivät oikein
prosessoituja, aktiivisia proteiineja ja niiden integraasit kykenivät integroimaan
siirtogeenejäkohdesolungenomiin.Siirtogeenienintegraatiopaikkojenjakaumallaonsuuri
merkitys vektorin potilasturvallisuuteen. Työssä osoitettiin myös mahdolliseksi muuttaa
lentivirusvektorin integraatiopaikkajakaumaa liittämällä integraasiin spesifisiä DNA
alueita tunnistava ja leikkaava IPpoImeganukleaasi. Integraation kohdentamista varten
meganukleaasiamuokattiinpoistaensenkykyleikataDNA:ta.Muutoksen jälkeenvektori
kykeni yhä ohjaamaan integraatiota kohdealueilleen eli ribosomin RNArakennetta
koodaaviin genomin osiin. Leikkaavaa IPpoI:tä sisältävää vektoria tutkittiin useissa
solulinjoissa sen solutoksisten vaikutusten selvittämiseksi. Suurilla annoksilla vektori oli
solutoksinenkaikissasoluissaeräidensyöpäsolulinjojenreagoidessaerityisenvoimakkaasti
käsittelyyn. Proteiinitransduktion toimivuus osoitettiinmyös in vivo –koesarjassa, jossa I
PpoIvektorikäsittely hidasti tuumorien kasvua. Meganukleaasin spesifisyys
kohdealueiden suhteen todettiin kromatiiniimmunopresipitaation ja genominlaajuisen
syväsekvensoinnin avulla. Villityypin integraasin ja kromatiinin interaktioita
kartoitettaessa havaittiin virusbiologisesti mielenkiintoisia eroja interaktio ja
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al., 2004). The first medicinal gene therapy product was approved into European/western
marketsattheendof2012whenGlyberaAlipogenetiparvovecreceiveditsapprovalafter
anarduousandtortuousprocess(YläHerttuala,2012;EuropeanCommission,2012).Despite






developed for the taskof transportinggeneticmaterial intocells.Gene therapyapproaches
usedifferentgenecarrierscalledvectors.Findinganddevelopingefficientandsafevectors




et al., 2008).Due to these risks, the gene insertion patterns of different vectors, aswell as
several methods of targeting the transgene insertion into safe sites are being intensely
studied.
Insomecases,genedeliverycanbesubstitutedbytransportingtheactiveproteins into the
target cells instead of DNA (reviewed byNoguchi andMatsumoto, 2006). The benefits of
such an approach include the possibility to more precisely regulate the concentration of
therapeutic protein in the target cells, while leaving the host cell’s genetic material
undisturbed.Aswiththegenetransfer,severalproteintransductionmethodsandtreatment
strategies also lack the necessary efficacy and/or targetability required for efficient clinical
use.





are presented for the first time. Protein delivery into target cells and targeted integration
were based on fusing the protein of interest into lentiviral integrase (IN), which is

















2.1 NON-RETROVIRAL VECTORS IN GENE THERAPY 
Virusesaresmallinfectiousagents,completingtheirlifecycleinsidelivingcellswithoutthe
capability of independent replication. Instead of synthetizing the components required for
the production of progeny virions (viral particles), they hijack the host cellmachinery for
theirreplication.Inordertoreprogramcellstostartvirionproduction,virusestransporttheir
genomes in a DNA or ribonucleic acid (RNA) form accompanied by the viral proteins
essentialforreplicationintothecell(Condit,2007).
Since viruses have evolved into efficient gene transfer machines, their research and
developmentasgenetherapyvectorsisnotsurprising.Inthebasicviralvectordesign(Figure
1), the genetic parts responsible for virus pathogenicity in the target cells, but not those
necessaryforthegenetransferarestrippedfromthevirus,andreplacedwiththetherapeutic
genes ina socalled transgenecassette. Inaddition toviruses,nonviralvectorscanalsobe
used for gene transfer. In nonviral field, awide variety of approaches, such as liposomal
encapsulationandpolymerconjugationareusedandcontinuedprogressisbeingmadealso
onnovelstrategies,suchasintramuscularinjectionofantisenseoligonucleotides(Kinalietal.,
2009).Most of thenonviral vectors aredescribed asbeing easy toproduce, relatively safe
andcapableof transporting large transgenes.However, theefficiencyofgene transferwith
nonviral vectors isusually lower than canbe achievedwithviral approaches (Vermaand
Weitzman,2005;Jacksonetal.,2006).Table1summarizesthemostpromisingvectorsystems.
 
Figure 1. General scheme of viral vector design and the production process. The wild-type virus 
genome is engineered so that the pathogenic elements unnecessary for the gene transfer and 
vector production are deleted. Genetic elements necessary for the virion structure and replication 
may be separated into two constructs. In the case of non-replicating vectors, elements necessary 











that will be later packaged into virions by the producer cell and transported into the target cells. 
Figure is based on the review of Verma and Weitzman (2005). 
 
 
Table 1. An overview containing five examples of some of the currently most important gene 
















Adenovirus 70-100 No 8.5 Short Easy to produce 




24 No 4.1-4.9 Long EMA approved Low transgene 
capacity 
Baculovirus 230-385 × 
40-60 


















Non-viral vectors - - - Short or 
long 
Safe, usually low 
toxicity, easy to 
produce 
Low efficiency of 
gene transfer 
2.1.1Adenoviruses
Family Adenoviridae contains several genera and numerous different viruses. Human
adenoviruses (later referred to simply as adenoviruses, Ads) are subdivided into seven
species from A to G. Within these species, over 57 serotypes have been recognized
(Buckwalter et al., 2012). Most adenovirus serotypes are associated with diseases of the
respiratory system,but for examplehepatic andurinary tract infectionsarealsoassociated
withAds.Thesymptomsareusuallymild,butinfectionswithsomeserotypes,likeserotype
14(Ad14)canhavemoresevereconsequences(Houngetal.,2010).
Physically adenoviruses are nonenveloped viruses with ~90 nm capsid diameter and
icosahedral conformation (Berk, 2007).Theirgeneticmaterial consistsofabout36kilobases
(kb) and is in the form of double stranded (ds) deoxyribonucleic acid (DNA). The 182
kilodalton(kDa)fiberproteinlocalizedintheviralcoatlargelymediatestheadenoviruscell
entrythroughcellularcoxsackieadenovirusreceptor(CAR[Bergelsonetal.,1997]).Afterthe
entry into cell, adenoviruses travel inside endosomesand subsequently access thenucleus,
wheretheviralDNAstaysinanextrachromosomalform(MeierandGreber,2004).
Currently (data from June 2012, www.abedia.com/wiley/) adenoviruses are the most
commonly used viral vectors in gene therapy clinical trials with 438 completed or ongoing
studiesaccountingfor23.3%ofalltrials.ThemostcommonserotypesusedareAd2andAd5.
Adenoviruseshaveseveraladvantagesasgenetherapyvectors:Theycanbeusedto transfer
up to 8.5 kb transgenes into dividing or quiescent cells,making it possible to target highly
differentiated nondividing cells, they can be produced with high titers of 10101011 viral











antibodies against the viruses. This causes rapid initial degradation of injected vectors and
decreases the efficiency of gene transfer. Studies have been conducted to find ways of




24 nm (Atchison et al., 1965). AAVs belong to the subfamily ofParvoviridae (International
Committee on Taxonomy of Viruses, 2011). They are not linked to any human diseases,
although most humans are seropositive to and therefore have been exposed to AAV
(Blacklowetal.,1968).SeveralfamiliesorcladesofAAV,includinghybridviruseshavebeen
found in screening of human samples (Gao et al., 2004). Aswith the other viruses in the
Dependovirus genus, they require a helper virus, a coinfection for example by adeno or
herpesvirus, in order to initiate productive infection leading to replication. In the case of
naturalinfection,AAVsaremostlypresentincellsasepisomalforms(Schneppetal.,2005).
AAV2 cell entrywithout the helper results in a latent infection through integration of the
linear singlestranded DNA genome into the host cell genome. A substantial fraction of









boundaries of AAV vector transport capacity, Dong and colleagues found the optimal
transgene length to be 4.14.9 kb and the maximum going up to 5.2 kb, after which the





2were conducted to treat theLeber congenital amaurosis (LCA) type2 – a severe formof
childhoodblindness.Inthe30patientstreatedthetrialsweresuccessful,leadingtoenhanced
visual functions in most of the treated eyes (Huang and Kamihira, 2012; Colella and
Auricchio,2012).AnothersuccessstorycanbeviewedinthetherapyoftheXlinkedbleeding
disorderHemophiliaB.Between2010and2011sixpatientswererecruitedtoparticipate in















therapymedicineapproved towesternmarketsas theEuropeanMedicinesAgency (EMA)
andtheEuropeanCommissionacceptedtheGlybera(alipogenetiparvovec),anAAV1vector






to “food we eat and the air we breathe” (Miller, 1997). Indeed, according to a study
conductedoncabbage from5differentsupermarkets in theWashingtonDCarea, some108
baculoviral particles per serving (100 cm2 of leafs) were found. The diverse baculovirus
family is divided into four genera with different insect hosts. Here the most studied
baculovirus,Autographacalifornicamulticapsidnucleopolyhedrovirus (AcMNPV), isusedas
anexampleanddetailedinformationisprimarilyAcMNPVspecific.
Baculoviruses have enveloped rodshaped capsids, composed mainly of VP39 capsid
proteins,with lengthof 230–385nmanddiameterof 40–60nm.Baculoviruses exist as two
possible forms:Asabuddedvirusoranocclusionderivedvirus (ODV).ODVsare further
arrangedintohighlystableocclusionbodies,whichcanwithstandavarietyofenvironments,
including the gastrointestinal tract of birds. The resistance ofODV helps in spreading the





Hu, 2005). Although they cannot replicate outside the order Lepidoptera*, cell entry
(Volkman and Goldsmith, 1983) and weak gene expression (Carbonell et al., 1985) in
mammaliancellswereidentifiedalreadyinthemid80’s.In1995itwasproven,byHofmann
et al., that when equipped with the right promoters BVs could be used for the efficient
transductionofmammaliancells.MammaliancellentryofBVshasbeensuggestedtooccur
via clathrinmediated endocytosis or macropinocytosis (Matilainen et al., 2005). The large
genome of baculoviruses (about 130 kb and 150 open reading frames (ORFs)) and their
flexiblevirionstructureallowpackagingoftransgenespracticallywithoutsizelimitation.The
gene expression obtainedwith baculoviruses is transient, although integration of pieces of
baculoviral genomehas been shownunder positive selection (Merrihew et al., 2001). In in










theyhave alsobeenused for theproductionof otherviral vectors – based for exampleon







are surrounded by membranes of endoplasmid reticulum (ER) “resembling small
cytoplasmicnuclei”(Tolonenetal.,2001).Anotherinterestingaspectisthevariousformsof
VACVvirionswithdifferent roles in the virus lifecycle. These are the robust intracellular
mature virus, membranewrapped intracellular enveloped virus, cellassociated enveloped
virus and as fourth form there is the extracellular enveloped virus. VACV has been
characterizedasabrickshapedparticlewithdimensionsof220450×140260×140260nm
(Smithetal.,2002;Johnsonetal.,2006).
Vaccinia is listed as a third most used vector in gene therapy trials after adeno and
retroviruses(datafromJune2012,www.abedia.com/wiley/).Thethirdplaceislargelydueto
itsuseinvaccinationstudies.VACVhasbeenalsousedonalargescale,sinceitwasthevirus
used in the eradication of smallpox. After vaccination against smallpox was no longer
recommendedbyWorldHealthAssembly, theuseofVACVas avaccineplatformagainst
other viruses was proposed at the beginning of 1980s. Vaccination have been achieved
through insertion of foreign virus gene into the vaccinia genome using homologous
recombination (Plotkin and Orenstein, 1999). The large, 190kb doublestranded DNA
genome,codingforover200proteins,allowsforadditionoflargetransgenes(Goebeletal.,
1990).ThedevelopmentofnoninfectiousVACVvectorpaved theway for itsuse forgene
transferpurposes(PlotkinandOrenstein,1999).

As an example of VACV applications, the modified vaccinia Ankara (MVA), a











superior to viral vectors in their safety, simplicity, easiness of production, price and low
immunogenicity. Viral vectors are, however, still the most efficient alternatives in
transportingandexpressinggenesintargetcells,at least intermsofefficiencyoftransgene
expression (Laitinenetal.,1997; reviewedbyPezzolietal.,2012).Thisdifference isat least
partlyexplainedbythedifficultyofendosomalescapeofnonviralvectors,andperhapsless






The easiest way to achieve foreign gene access into the tissue is by nakedDNA injection
(Wolff et al., 1990). The vector in this case is a circular plasmid,which in addition to the
elements required for bacterial production, consists of a promoter, transgene and
polyadenylation signal for the messenger RNA (mRNA) nuclear export. Simple injection
usually leads to very low and transient gene expression. The duration of plasmid vector
expressioncanbeehancedbyadditionofscaffold/matrixattachmentregion(S/MAR),which
have been associatedwith longterm transgene expressiondue to the episomalpersistence
andinhibitedmethylation(Argyrosetal.,2008).Alsotheinjectiontechniques,especiallyfor
myocardial therapies, have been improved, for example due to the development of
percutaneousintramyocardialinjectioncatheters(Valeetal.,1999;Valeetal.,2001).Thereare
some physical methods, which can improve plasmid transport e.g. particle bombardment
(Yangetal., 1990)whereDNAiscoatedontometalparticles,whichare then fired into the
cells at high velocity and electroporation (Neumann et al., 1982), in which brief electric
impulses are used to permeabilize the cell membrane. Despite the technical challenges,
electroporationtechniqueshavebeenprovedtoworkalsoinvivo(MiyazakiandAihara,2002;
Marshalletal.,2010).AnotherwayofboostingDNAintakewhenusinginjectiontechniques
is receptormediated endocytosiswhere DNA is linkedwith specific endocytosisinducing
molecules (Wu andWu, 1987;Wu andWu, 1988). The cell penetrating peptides / protein
transduction domains can also be used for plasmid transport (see chapter 2.5). Since the
plasmidvectorscannotprotectthetransgene,whichwouldbeimportantespeciallyafterthe
systemic injection, DNA will be degraded at a rapid rate (Kawabata et al., 1995) and in
replicatingcellstheDNAcontentwillbedilutedwitheachcelldivision.Thedilutioneffect
doesnot,however,fullyexplainthelossofexpressionsinceusuallygenetherapiesaretested







Sleeping Beauty transposon system (SBTS) is based on the natural genetic transposable
element(Ivicsetal.,1997).Thesystemconsistsofageneexpressioncassetteinsertedintothe
transposon DNA and a separate source of the transposase protein which need to be co
delivered into the same cell. The transposase reaction results in the integration of the
transgenesothatitbecomesapartofthehostcell’schromatin.SBTSdoesnothavetheability
tomovematerial into the cells and therefore cDNAscoding for transposaseand transgene
needtobeinjectedorotherwisetransportedintothecells(Aronovichetal.,2011).
The chemical methods of nonviral transgene delivery are generally based on cationic
liposomes, whose positive charge in physiological pH leads to their interaction with the
negatively charged DNA, after which they form nanoscale complexes called lipoplexes.
LiposomesareeffectivecarriersofDNA,protectingthetransgenecargofromnucleasesand
leading to efficientDNA internalization through endocytosis (Felgner et al., 1987;Nicolau
andCudd,1989;WrobelandCollins, 1995).There is,however, cytotoxicityassociatedwith
theuseofbothcationiclipidsandpolymers,whichmayrestricttheirusage(Lvetal.,2006).
Inordertocombinethebestqualitiesofseveralapproaches,virusderivedcomponentshave










bacteria that can seek out tumour microenvironmentalike hypoxic areas and replicate in
theseregionswhileexpressingthetherapeuticgene(Nemunaitisetal.,2003)*.Inadditionto




promoteroraccesstothenucleusandcannot integrate intothegenome, thus increasingits
safetyprofile(Tavernieretal.,2011).

2.2 RETRO- AND LENTIVIRUSES AS GENE THERAPY VECTORS 
ReversetranscriptionisthehallmarkofvirusesofthefamilyRetroviridae,retroviruses,which
reversetranscribe their plusstranded RNA genome into double stranded DNA. Another
specific,althoughnotunique,featureofretrovirusesistheintegrationreaction.Asaresultof
integration, theviralgenome is covalently,and thereforepermanently, joined into thehost
cell chromatin.Retroviruses are furtherdivided into two subfamilies,which contain seven
genera: Alpha, beta, gamma, and epsilonretroviruses, lentiviruses and spumaviruses
(Baumetal.,2006).Retrovirusesareubiquitousanddiverseinnature.Differentretroviruses
are found from most vertebrates. Due to the integration their transmission can be either
horizontal,mediatedbysingleinfectiousviralparticlesinfectingnewcells,orvertical,where
theendogenousintegratedprovirusistransmittedwithinthegermline.Horizontalretrovirus
transmission can also happen through celltocell contact (Hooks et al., 1976; Gupta et al.,







transgene, which is based on their ability to covalently join transgenes into the host cell
genome. Retroviral vectors have been investigated since 80’s, and even though major
progresshasbeenmadeinsomeareas,significanthurdles,notablyinsertionalmutagenesis,
remainbeforeretrovirusescanbeconsideredforroutineclinicaluse (PagesandBru,2004).
Lentiviruses are a subclass of retroviruses, which, unlike several other retroviruses, are
capable of infecting also nondividing cells (Weinberg et al., 1991; Lewis et al., 1992;
Bukrinskyetal.,1993).
Retrotransposons are genetic elements resembling largely retroviruses, but lacking the
extracellularphaseinthelifecycle.Thesimilaritytoretrovirusescanbeseeninthebehavior
aswellasinsomecasealsoinsequencelevelwithahighdegreeofhomologybetweenthese
two (Sandmeyer et al., 1990). More than 40% of mammalian genetic material can be
consideredasbeingremnantsofancienttransposableelements.Mostofthesegenomicrelics










Retroviruses were discovered at the beginning of 1900, when it was shown by Vilhelm
Ellermann,OlufBangandPeytonRousthatchickenleucosisandsarcomaswerecausedbya
virus*,subsequentlynamedasRousSarcomaVirus(RSV).AfterthediscoveryofRSV,new
retroviruses were found infecting multiple vertebrate species (Rous 1911a; Rous 1911b;





was acceptedwhen Temin and Baltimore demonstrated reverse transcription in retrovirus
infected cells (Baltimore, 1970;TeminandMizutani, 1970).Asa resultof these studies, the
Nobel prize in physiology or medicine was awarded in 1975 to David Baltimore, Renato
Dulbecco and Howard Temin for their discoveries concerning the interaction between
tumourvirusesandthegeneticmaterialofthecell(KarolinskaInstitutet,1975).
Despite intensive search efforts, human retroviruses were not identified until the 80´s.
Althoughretroviruseshadpreviouslybeenshowntoinfectothervertebratespecies,several




2, which is a Tcell growth factor, the longterm culture of human lymphocytes became
possible. Subsequently Tcell malignancy associated HTLV1 was found in a Tcell line
originating fromapatientwith cutaneousTcell lymphoma in 1979 andpublished in 1980
(Poieszetal.,1980;Yoshidaetal.,1982).Ananecdotedescribingaforementionedprejudices
against the existenceofhuman retroviruses is thatwhenGallo first submitted theHTLV1
article to the JournalofVirology itwas rejectedwith the editor insisting that they should
cease, andnot continue toperpetuate the controversy, strongly implying thatweall know
humanretrovirusesdonotexist(Vahlne,2009).
Human immunodeficiencyvirus (HIV)of lentivirusgenus is thebestknownandprobably
themostwidelystudiedretrovirus.TheeventsleadingtodiscoveryofHIVandconfirmation
ofitsroleasacausativeagentofAIDS,aswellastheconsequencesthatfollowedhavebeena
topicofdebate.AIDSwas first reported in theUnitedStates in1981. Initially therewasno
clearviewonthediseaseoritscause.Atfirst,theindividualsatriskwerehomosexualmen



















paperdescribing the isolationof anewLAVlikevirus, this timedemonstrating lentivirus
likemorphology(Vilmeretal.,1984).Althoughthis[orthese]publicationscanbeconsidered
asthefirstdescriptionsofHIV,itsroleintheAIDSepidemicwasnotyetestablished.OnMay
1984Galloandcoworkerspublishedfourpapers inaspecial issueofScience inwhich the
authorsforthefirsttimeproposedHIV(atthattimecalledHTLVIII)asthe“primarycause









HIV emergence is not known, but thevirushasbeen around for at leastdecades,perhaps
evenonehundredyears,beforetheepidemic“exploded”andwasdetected(Jaffaretal.,2004;
de Sousa et al., 2010; De Cock et al., 2011). TheAIDS epidemic changed its course into a
painstakingly slow decline at the turn of the millennia. According to United Nations
UNAIDS HIV/AIDS program, during 2009, 33 million people were living with HIV, 2.6





retrovirus, around 1.161.18 g/ml (Forshey et al., 2002). It consists ofRNA, fifteenproteins
and a lipid bilayer envelope (Figure 2). Virions are sensitive to heat, formaldehyde and































TM) (Veronese et al., 1985). Under the matrix, the conical shape structure typical for
lentiviruses,thecapsid,canbeseen.Thisconsistsofthecapsidprotein(p24,CA)(Nakaiand
Goto, 1996). Inside the capsid lies the single stranded viral genomepresent in two copies,
whichareshieldedbynucleocapsidproteinsp7(NC)andp6(FrankelandYoung,1998).With
theexceptionofp6,thestructuralproteinsaregenerallycommontoallretroviruses.
In addition to the aforementioned structural proteins, the HIV virion also contains three
enzymatic proteins. These are the integrase (p32, IN), protease (p10, PR) and reverse
transcriptase(RT),whichhastwosubunits,p66andp51.Inadditiontothese,HIV1codesfor
two regulatoryproteins,Tat andRev, and four accessoryproteinsVif,Vpr,Vpu, andNef.
Theregulatoryandaccessoryproteinsarespecifictocomplexprimatelentiviruses,although









Table 2. HIV-1 proteins and their main functions. It is noteworthy that especially the regulatory 
and accessory proteins of HIV-1 are highly pleiotropic and may perform a variety of tasks in 
addition to those listed in the table. Proteins marked with * are present in common 3rd generation 




LVV Gene Function/structure 
Matrix, p17, MA Structural * gag Outer protein layer underneath 
the lipid membrane 
Capsid, p24, CA Structural * gag Cone-shaped virion capsid 
Nucleocapsid, p7, NC Structural * gag RNA-packaging, RNA chaperone 
p6 Structural * gag Vpr-packaging, regulates the exit 
of virions from the cell 
Surface protein, gp120, SU Structural  env Virion surface receptor, mediates 
binding to target cell 
Transmembrane protein, gp41, TM Structural  env Structural transmembrane protein 
Protease, p10, PR Enzymatic * pol Polyprotein cleavage during virion 
maturation 
Reverse transcriptase, p66&p51, RT Enzymatic * pol Reverse transcription of viral RNA 
Integrase, p32, IN Enzymatic * pol Integration of viral genome into 
host cell genome 
Tat Regulatory  tat Transcription transactivator, 
upregulates viral gene expression 
Rev Regulatory * rev Genomic mRNA transport into 
cytoplasm 
Vif Acessory  vif Increases the infectivity, 
diminishes the activity of antiviral 
APOBEC3F and APOBEC3G, role in 
virion assembly 
Vpu Acessory  vpu Enhances the exit of virions from 
the cell 
Vpr Acessory  vpr Cell cycle arrest, regulator of 
apoptosis 




Common routes of HIV1 infection are sexual intercourse, perinatal transmission (from
mother to child), and transmission through blood transfusion or intravenous drug use
(Hansasuta, 2001). Virus infection (Figure 3) requires two viruscell interactions: First the
gp120glycoproteinbindstoCD4proteinonCD4+Tcells,dendriticcellsormacrophagesand







Figure 3. Illustration of HIV-1 life cycle. Infection begins with binding of the viral surface proteins 
to host cell receptors (1). Binding triggers the membrane fusion (2), after which the viral core 
enters the cytoplasm (3) where uncoating of the capsid and reverse transcription (4) of the viral 
RNA into DNA takes place. After reverse transcription the preintegration complex (PIC) moves 
into nucleus, where the viral genome is integrated into host cell genome (5). Production of 
progeny virions starts with the transcription of integrated provirus (6), when new viral genomes 
and mRNAs for viral protein translation (7) are produced. The assembly (8) and budding (9) of 
nascent virions takes place at the cell membrane. Newly formed virions undergo a maturation 
process before becoming infectious. 

The fusion of the virus and host cell membranes happens in 1  3 minutes. The fusion
proceedsusuallywithoutanycytotoxiceffectsinthehostcells,althoughonsomeoccasions
membrane rupture may be induced (Grewe et al., 1990). After the membrane fusion, the
matrix isdissociated (uncoating) and thevirus core is released into the cell.Once the core
entersthecytoplasm,thereversetranscriptionreaction,aswellasdissociationofthecapsidis
initiated. After the completion of reverse transcription in 8 to 12 hours, the formed
nucleoproteincomplexiscalledpreintegrationcomplex(PIC[FassatiandGoff,2001;DeRijck




as HMGI(Y) and the barriertoautointegration factor (BAF), which prevents the viral
autointegration(LeeandCraigie,1998;LinandEngelman,2003).PICisfirstlocalizedinthe
cytoplasmwhich is crowdedwithdifferentmolecules and structures. In this environment,
BrownianmotionanddiffusionofalargeparticlesuchasPICisveryrestricted(LubyPhelps,
2000). PIC uses cellular machinery and microtubules for active transport on its passage








Figure 4. HIV-1 reverse transcription mechanism. tRNA (blue) bound to PB in the gray HIV-1 RNA 
genome (1), synthesis of short complementary DNA strand (black) and RNA degradation (2), 
minus strand transfer (23), alignment of the newly synthesized DNA with viral RNA and 
subsequent synthesis (3), start of the plus-strand synthesis on orange (4), plus strand transfer 
(45) and the finishing of the plus-strand synthesis (dark blue on plus-strand and gray on minus-
strand). For simplicity, the central DNA flap synthesis has been omitted. 
Reverse transcription ofHIV1 can be consideredmolecular acrobatics (Figure 4). Reverse




strandDNA towards the endofviralgenomecontainingU5andR sequences.RTexhibits




with it the newly synthesized DNA. At the end of the strand transfer process, the
complementary R sequences of both DNA and viral RNA are annealed. After the strand
transfer,theminusstrandDNAsynthesisandRNaseHdegradationofRNAcanprogressall
thewaytothe5’PBsite.
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The synthesis of the plus strand using RNA primers starts from two separate sites: The









plasmamembrane. Ithasbeenproposed thatviralaccessoryproteinNef interactswith the
actinnetworkandinducesitslocalrearrangement,facilitatingPICaccesstomicrotubulesand
entry deeper into the cell (McDonald et al., 2002; Matarrese and Malorni, 2005). After
microtubuleassisted fast (0.11m/s)movement, PIC once againmakes contact with actin
filamentsbeforereachingthenuclearenvelope(Arheletal.,2006).
InordertogainaccesstothehostcellDNAforintegration,thePICmusttraversethenuclear






capsid containinghybrid viruseswere used, leading to impaired infection in nondividing
cells(YamashitaandEmerman,2004),wherethenuclearmembranerestructuringassociated
with celldivisionwasabsent.Thepleiotropicnatureof theviralproteinsmakes ithard to
drawany firm conclusionson this topic, but the capsidprotein clearlyplays a role inPIC
nuclear entry. After successful transport through the nuclear pore complex, PIC comes to
contactwithchromatinandINcatalyzesthecovalentjoiningoftheviralgenomeintothehost
cellgenome(Arheletal.,2006;Arhel,2010).
TheLTR element acts as a promoterwhen the virus production starts from the integrated
provirus. Both cellular and viral proteins affect the process. Viral Tat enhances the
transcriptionandRevregulates theRNAsplicing(Feinbergetal.,1986;Malimetal.,1988).
BeforeTat is transcribed, only a very limited amount of viral gene expression takes place.





exit bybuddingat theplasmamembrane takingwith thema smallpart of themembrane.
GenomicRNAispackagedviathecontactsbetweenNCandacisactingpackagingsignalat
the5’endoftheviralgenome(GeigenmüllerandLinial,1996).Buddedvirionsarenotready
for infection of new cells before they go through the process of maturation, where viral
precursorpolyproteins inside the virus particle are cleaved into functional proteins by the



















both ends of the provirus. LTRs perform a variety of functions during the viral life cycle.
TherearesomeespeciallyimportantpartsoftheLTRse.g.Rareasfortheircoordinationin
reversetranscription,theattsequencesthroughwhichtheINbindstotheviralgenomeand
the TATAAbox containing upstream U3, which acts as an enhancer and polymerase II










In addition to the LTRswith the primer binding site therein, the cPPT area located in the
middle of the genome is important for the DNA flap formation during the reverse
transcription and therefore for the uncoating at the nuclear pore and PIC nuclear import
(Follenzietal.,2000;Arheletal.,2007).TheRevresponseelement (RRE) located in theenv
coding region contains binding site for the Rev protein. Through this interaction, Rev
stabilizes the mRNA produced by proviral transcription, directs its splicing and then
promotesitsnuclearexport(Haseltine,1991).
ThepackagingsignalorPsielement, isanareacontaining4stemloopspartlyoverlapping
with the gag start codon. mRNAs containing the packaging signal are those that will be
packaged intonewly formingvirions (Leveretal.,1989;Zeffmanetal.,2000).Aconserved
sequence called the slippery site is the site responsible for the programmed 1 ribosomal
frameshifting that occurs between gag and pol reading frames, which are translated in
different reading frames. The slippery site and a nearbyRNAhairpin thereby ensure that
polyproteinsGagandGagPolareproducedattherightratios(9095%Gag510%Pol)(Jacks
etal.,1988;Biswasetal.,2004).
HIV1 structural and enzymatic proteins are coded from gag, pol and env genes, whereas
accessory proteins have separate genes of their own. The expression of gag, pol and env








forms a heterodimer with the noncleaved p66 form (Wang et al., 2000). Taking the
aforementioned efficiency of 1 ribosomal frameshifting into account, the maximum copy





in cell culture and samples fromAIDS patients (Michael et al., 1994; Ludwig et al., 2006).
Despite the exciting findings of antisense transcription in HTLVI (Larocca et al., 1989;
Gaudrayetal.,2002),theHIV1antisensetranscriptionhasnotbeencompletelyclarifiedand
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coding for thenecessary elements for vectorproduction, the socalledhelper elements, are
expressed separately from the rest of thegenome in aproducer cell, intowhich thevector
RNAgenomecontainingthetransgeneandpackagingsignalisintroduced.Thisleadstothe
formation of vector particles with transgenes inside them (Naldini et al., 1996). Generally
HIV1vectorshavebeen thought tobe capableof carrying transgene cassettes roughly the
samesizeasthewildtypegenomes(Terwilligeretal.,1989).Accordingtosystematicstudies
by Richard Sutton and coworkers (Kumar et al., 2001), the gene transfer efficiency of
lentiviralvectordropslogarithmicallyasthetransgenesizeincreases.Still,aslongas18kb
transgene could be used in transduction, albeit with a titer no more practical from a
therapeuticpointofview.
In lentiviralvectorsystems, theDNAelementsnecessaryforvectorproductionaredivided
between separate plasmids for safety reasons. Lentiviral vector development took place in
threegenerations,whicharesummarizedintable3.Usuallythevectorenvelopeglycoprotein
genesarenotofwildtypeHIVorigin,butarechosenfromseveralalternatives.Changingthe
viral envelope into that of another virus is referred to as pseudotyping. One of themost
widelyusedoptionsispseudotypingthevectorswithvesicularstomatitisvirusglycoprotein






In order tomake the vector system suitable for future use in therapeutic approaches, five
virulencerelated genes env, vif, vpr, vpu, andnefwere deleted from the second generation
vector(Zuffereyetal.,1997).
The third generation LVV (Dull et al., 1998) was still one step forward in the process of
stripping the vector system of all unnecessary or replaceable viral elements. The major
changes characterizing 3rd generation LVV are the deletion of the tat gene and the trans
complementation of rev from a separate plasmid. Transactivator of transcription, Tat,
increasesthelevelofHIV1provirustranscriptionelongationduetoitsinteractionwiththe
transactivationresponseelement(TAR)stemloopstructureinthe5’endofthenascentviral
RNA. Without Tat, only a few RNA molecules are produced by provirus transcription
servingasatemplatefortheproductionofTatproteins,whichinturnbindtheTARelement
and increase the RNA polymerase II transcription of a fulllength virus through a cyclin





plasmid split genome system (see figure 22 for overview). As in the earlier generation
systems, the transfer element (containing the transgene) and envelope are situated on
separateplasmids,butinadditionthebulkofthehelperfunctionsandRevhavebeenfurther
divided into two separate nonoverlapping plasmids. Gag and Pol protein expression is
drivenbyCMVpromoterinpMDexpressionvectorcontainingalsoaninterveningsequence











EcoRV site for the recognition and processing by IN and 18 nucleotides for the
polyadenylation downstream of the PvuII site. SIN deletion removed the LTR promoter
activity without significantly reducing the overall titers during production or altering
expressionlevelsintargetcellsaftertransduction.SINmodificationrepresentsanimportant
safetyaspectbyblockingthefulllengthvectorRNAsynthesisandreducingtheprobability
of any production of replication competent lentivirus (RCL). However, residual promoter
activityhasbeenreportedforintegratedSINvectors(Loganetal.,2004).
Table 3. A summary of the three generations of lentiviral vector systems. 
 
Vector system Plasmids Properties Reference 
1st generation 3 Contains all HIV-1 genes except the env L Naldini et al., 1996 
2nd generation 3 No accessory genes in packaging plasmid Zufferey et al., 1997 
3rd generation 4 Deletion of the tat and trans-complementation 
of rev from a separate plasmid 
Dull et al., 1998 
3rd generation SIN 4 Self-inactivation due to U3 LTR deletion Zufferey et al., 1998 
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only individual INdomainstucturesweredeterminedandseveralmodels for thestructure
andpossiblemultimerization of intact INwereproposed.Allmodelswereproven at least









phylogenically conserved D, D35E motif. These sites coordinate the positioning of
magnesiumionsinthecatalyticcore.MutationsinanyofthesesitesimpairstheINcatalysis





several other INmutations. The remaining integration activity is believed to bemostly or
totallynonintegrasemediated(GaurandLeavitt,1998).D64Visthemostcommonmutant
in integration deficient lentiviral vectors (IDLVs (Wanisch and YáñezMuñoz 2009)). It is
noteworthythattheretroviralintegrationreactioncloselyresemblesthatoftransposition,for
example by Mu phage transposase. Even though the overall protein similarity between
transposaseandINislow,thecentralcoreoftheseproteinshasbeendescribedas“strikingly
similar”(Riceetal.,1996).
The CTD (aas 213218) contains the nuclear localization signals of several retroviral and
transposon INs, although at the general level, it is the least well conserved domain. CTD
binds DNA with high affinity even without the metalions, unlike central domain
(HindmarshandLeis,1999).
Figure 8. HIV-1 IN structure with emphasis on catalytical core domain. Location of important 
amino acids is shown. Figure is based on (Poeschla 2008). 





The first phase in the integration reaction (Figure 9) takes place already in the cytoplasm,
whereINmediatesthe3’endprocessingstep.Inthisstep,theterminalGTdinucleotidesare
removed from the 3’ viral DNA ends, revealing conserved CAdinucleotides common to
several retroelements and their 3’ terminal hydroxyl groups, which will serve as a





After the ligationof3’ strands, the5’ strand is left loosewithaCAdinucleotideoverhang.
The repair of host DNA after integration requires cleavage of these overhanging sections,
filling the singlestranded parts with the complementary sequence and finally ligation
reaction takesplace to join thestrands.Therepairprocessresults induplicationof the five
base pairs flanking the integration site (Dhar et al., 1980; Hindmarsh and Leis, 1999;
Marchandetal.,2006;Maertensetal.,2010).
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Figure 9. HIV-1 IN integration mechanism as presented in the text. The provirus with four 
nucleotides at both ends is shown. In the 3’ processing, GT-dinucleotides are removed, after 
which IN joins the 3’ ends with the chromatin. Figure is based on Freed and Martin (2007). 
Althoughprovirus integration is required for efficientHIV1 replication (Sakai et al., 1993;
Caraetal., 1995),a substantialamountofnonintegratedviralDNAcanbedetected in the
hostcells(Shawetal.,1984;Pangetal.,1990).UnintegratedDNAhasbeenshowncapableof
expressing HIV1 genes (Stevenson et al., 1990), and it is not considered as a deadend
product,butratherasapoolforrecombinationinthecaseofcoinfectionwithanintegrated
virus.Incoinfection,viralgenomesproducedfromunintegratedDNAmaybepackagedinto
budding virions, thereby preserving viral diversity (Gelderblom et al., 2008).Unintegrated
viralDNAisusuallypresentinthecellsasalinearformorinthe1or2LTRcircles(Figure
10).Socalledautointegrationproductsresemble1and2LTRcirles,butthereisvariabilityin
their length and composition.When expression of transgenes is driven from the episomal








Figure 10. HIV-1 linear genome has several possible fates after the infection. In addition to 
autointegration products and the integrated provirus, 1-LTR circles can arise through the 
recombination of homologous LTR-parts, 2-LTR circles can be created for example through the 
non-homologous end joining pathway, or the viral DNA can be degraded by the host cell 
machinery. Figure is based on by Sloan and Wainberg (2011).

2.3.3IntegrationsitedistributionofHIV1basedlentiviralvectors
The obvious question related to integration reaction, whether it is integration of virus or
someotherretroelement,isthedistributionofthesitesofintegration.Intheinitialretroviral
integrationsitestudies, integrationwasthoughttobeamoreor lessrandomprocessinthe
(Shimotohno and Temin 1980; Sandmeyer et al., 1990), as it may seem at first glance.
Subsequent studies have shown that different lenti and retroviruses have distinct
preferencesfordifferentareasastheirtargetsforintegration.Althoughthekeymechanisms
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CpGisland are chromosomalareaswhichareusuallyassociatedwithgene regulationand
transcription factor binding sites and are therefore located mainly in generich areas
(reviewedbyDeatonandBird,2011).ForMLV,thesesitesarefavoredtargetsofintegration.
ForHIV1,thereisactuallyanegativecorrelationbetweentheimmediatevicinityofCpGsite
and the integration probability. Thus, inside generally preferred generich areas, there are
local disfavored sites, such as CpG islands (Mitchell et al., 2004). In eukaryotic genomes,
chromatinformsintranucleardomainsthroughbindingwiththenuclearmatrixthrough200
300 bp matrix attachment regions (MARs). When Kulkarni et al., (2004) analyzed the
integrationsitesgeneratedbySchröderetal.,(2002),theyfound485outof524(92.5%)HIV1
integrationsiteshadaMARwithin±5kbpdistance.
In 2007 Bushman’s group published integration site results from a large pyrosequencing
study (Wang et al., 2007).Over 40000 integration sites included in the dataset gave it real
credibility and statistical power compared to any previous study.Using this data and the
nucleosome mapping method deviced by Segal et al., (2006), they demonstrated that the
integration to favoured “outwardfacing major grooves on nucleosomewrapped DNA”.
Theyalsolinkedseveralhistoneposttranslationalmoficationsintointegrationsiteselection.
Asemphasizedoutalsoinearlierstudies(eg.HolmanandCoffin,2005;Wuetal.,2005),large
pyrosequencing data confirmed a weak consensus sequence, with a core element
GT(A/T)AC,  for the immediate area housing the integration site at base positions 3 to 7
relativetothepointofintegration.TheweaknessoftheconsensusisseeninthedatabyWu
etal.whereonly10sitesoutof334hadthefullcoresequenceatthesiteofinsertion.
Lens epitheliumderived growth factor/p75* (LEDGF/p75), reviewed from HIV pointof
viewbyPoeschla(2008),isanubiquitouslyexpressedtranscriptionalcoactivatorwhichhasa
cellularresponseof731transcriptionunitsbeingupregulatedand835downregulated(Wang
et al., 2007). It was not linked to HIV until Cherepanov et al found that LEDGF/p75
coprecipitated with IN from the nucleus (Cherepanov et al., 2003). Among retroviruses,
LEDGF/p75was found toundegoadirect interactiononlywith lentiviral INs (Llanoetal.,
2004;Cherepanov, 2007). An interesting fact is thatLEDGF/p75 integrasebindingdomain
(IBD) is conserved in vertebrates (Vanegas et al., 2005) and another human protein,
hepatomaderived growth factorrelated protein 2 (HRP2) shares the same structure
(Cherepanov et al., 2004). Soon it became evident that LEDGF/p75 was the molecule













Figure 11. LEDGF/p75 INtethering. LEDGF/p75 binds to chromatin and INs in PIC. The PWWPdomain (
















Nterminal fusion of IN with the DNA binding domain of bacteriophage lambda (
)
repressor (
R), and postulated that targeting could be used in gene therapy. In in vitro
reactions,wherephageDNAwasusedasatargetinthetesttubesetting,thefusionprotein




(Bushman andMiller, 1997) a Cterminal fusion of IN and a sequence specific zinc finger
protein(zif268,PavletichandPabo,1991).Theyshowedincreasedintegrationneartozif268
targetsites.Howevermorerelevantinthecontextofthisthesis,istheobservationthat,while
virions containingonly INzif268 fusionproteinswere largely impaired in their replication
efficiency, virions containingmixtures ofwildtype IN and fusionproteinwere capable of
undergoingreversetranscriptionandintegration.
ThesecondgrouptoaimfortargetedintegrationusedasimilarapproachoffusingINtoa
DNA recognizing protein (Goulaouic and Chow, 1996). This time E.coli LexA protein









sequence, in an in vitro assay. Katz et al also experimentedwith LexA fusion using avian
sarcomavirus(AVS)INwithsimilarresults(Katzetal.,1996).Inadditiontotheinvitrodata,
theyshowedthatthefusionINcouldbepackagedintoAVSvirionswithoutcompletelossof
replication capability, although expression of the fusion protein was lost during viral









IN inactivated, using the transpackaging method (presented in chapter 2.5.2). Despite a
reduction in integration efficiency, a polymerase chain reaction (PCR) method capable of
detecting integrations froma6kpbarea surrounding target site showedanevidence foran
almost tenfold increase in target integrations i.e. from 0.15% with wildtype controls* to
1.48%withthebestfusionproteincontainingviruses.
Despitethispromisingoneorderofmagnitudeincreaseintargetintegrationprobability,new
targeting HIV1 INfusions were not described for several years after these initial
experiments. Possible reasons lie in problemswith transpackaging, loss of infectivity and
difficulties related to genomicCterminal IN fusions, as discussed by Tan et al., (2006). In
theseearlygenerationvectors, the3’endof INoverlappedwithavif codingsequenceand
containedaspliceacceptorsite.Fusionswerealsoconsidereddetrimentaltoproteinfolding
andpackaging. It isprobable thatalso the findingofLEDGF/p75 (Cherepanovetal., 2003)
and its role for integration (Llano et al., 2004; Cherepanov, 2007) shifted the focus. One
indicationforthisspeculationisthesubsequentpublicationofLEDGF/p75testedasafusion
fortargeting(Gijsbersetal.,2010).
In addition to IN fusion proteins, there are severalways to target integration, but still no
clinicallyprovenmethodexistswhichwouldbesuitableforgenetherapyapplications.Some
of the methods are rather robust and work well at the cellular level, but their delivery
representsanobstacle.Manyapproachesarebasedonhomologousrecombination(HR)and
the use of IDLVs (Wanisch and YáñezMuñoz, 2009). IDLVs can be used to transport the
transgenewithtargetspecificzinf fingers(Carroll,2011), transposonsystems(Owensetal.,
2012) or transcription activatorlike effector nucleases (TALENs, Bogdanove and Voytas,
2011)inattemptstogeneratedoublestrandbreaks(DSBs),whichwouldincreasetherateof
HR. Lately Gijsbers and coworkers published a proofofprinciple study (Gijsbers et al.,
2010), in which the area of LEDGF/p75 interacting with chromatin was replaced by
heterochromatinprotein1(CBX1),whichisbelievedtolocalizetogenesparseareasofthe










2.4 GENE THERAPY CLINICAL TRIALS USING LENTIVIRAL VECTORS 
Althoughgenetherapyismovingforwardsalsointhewesternworld(YläHerttuala,2012),
viralvectorsbeingadministeredtopatientsarestillmainly*thoseproducedforclinicaltrials.





required for vectorproduction.One of theplasmids contains the sequence ofLTRflanked
transgene cassette and packaging signal while the others provide the necessary viral
componentsandaccessory functions.Thedayafter the transfection, the culturemedium is
changed,andthecellsarethenincubatedfor2448hoursafterwhichthemediacontaining
thevectorsiscollected.ThecollectedmediacontainstheproducedLVVsanditisreadyfor
use in the experiments. If it is necessary to achieve higher viral titers, vectors can be
concentrated by ultracentifugation at 100000×g (Wang and McManus, 2009). Crude







is that there should be adherence to the good manufacturing practice (GMP), a set of




antigen,which increasesvirusyield andallows repeatedpassagingof the transduced cells
withanegligibleimpactonvirusproduction(Grahametal.,1977;Ausubeletal.,2012).Cell
culturingmethodsforproductionareeitheradherent,i.e.whenthecellsremainattachedto
the surface of the cell culture dish, or suspension based,where the cells are suspended in
media being constantly in movement. The problem with adherent cells is the large area
needed to grow them in suitable numbers and the challenge of upscaling the system,
although multitray plasticware has alleviated this problem (Karolewski et al., 2003).
Adherentcellsalsoneedtobedissociatedfromthesurfacebeforetheycanbehandledinthe
liquid. In the suspension production, huge cell numbers can be grown per volume, but
maintainingthepH,O2,wasteproductsandnutrientlevelsaswellasmixingshearforcesat
the correct level can be demanding (Merten, 2004). With the availability of single use
bioreactors, e.g the rockingwave systems (Singh, 1999) suspensionproductionhasbecome
easier and less demanding in terms of some of the technical aspects (Smelko et al., 2011).
There are also alternative or hybrid culture methods available, such as the use of
microcarriers (Levine et al., 1977),where cells are cultured on the sides of small flakes or
spheresfloatinginthemedia.Itisnoteworthythatthehalflifeofvectorparticlesaftertheir
production at 37°C degrees (between 9 and 12 hours) is ~5% of that in the cold room











the production of clinical material (Levine et al., 2006). DNA can form a precipitate with
calciumionswhenmixedwithcalciumchlorideintoasuitablebufferedsolution.Theprocess
is cheap and quite reliable when performed by an experienced operator. With certain
limitationsCaPO4transfectioncanalsobeusedinlargescalesuspensionproduction(Girard
et al., 2002). As already described in chapter 2.1.5, in nonviral gene delivery methods,
cationicpolymers andpolyethylenimine (PEI) are efficient tools for transfection (Pezzoli et










Clinical trials demand for high product purity and usually the ability to purify the crude
vector containingmedia, not the sheer upstream capability represents themost significant
technical difference between units capable of clinical material production and those who
produceonlyforresearchpurposes.Lentiviralvectorparticlesarefragileandcareneedsto
be taken when designating the purification parameters in order to minimize shear stress.
Usually lentiviruspurification reliesheavilyonanionexchange chromatographycombined
with tangential flow filtration techniques (Bandeira et al., 2012). In addition, innovative
alternatives,suchasastepfiltrationprotocolusingaseriesoffiltersthatareroutinelyusedin
bloodbankingpurposes,havebeenusedforlargescalevectorpurification.Sinceantibiotics









line, thisdepicts theriseof lentivirusvectorpopularity in itsclinicalapplications.The first
reported application for the use of lentiviral vectors in clinical trialswas an antiHIV trial
withaconditionallyreplicatingvector,wherethetransgeneusedwasanantisensesequence
againstHIV (Levine et al., 2006).Thevector systemusedwasVSVGpseudotypedVRX496
(Luetal.,2004)producedbyVIRxSYSwiththeir2plasmidsystemusingCaPO4transfection
ofHEK293cellsin10layercellfactories.Afterseveralharvests,thevectorwasconcentrated
and purified by ultrafiltration and sizeexclusion chromatography. The trial consisted of a
singledoseofexvivovector transducedautologousCD4+Tcellsadministeredto fiveHIV
patients. In four out of five patients, conditional vector replication and improved immune









in the case of Xlinked Severe Combined Immunodeficiency (SCIDX1) (CavazzanaCalvo,
2000; Wiznerowicz and Trono, 2005). As shown in the treatment of Xlinked
adrenoleukodystrophy (ALD, Cartier et al., 2009), lentivirus vectors can provide the high
transduction efficacy needed in the treatment. ALD is a fatal brain demyelinating disease
causedbymutations inABCD1gene.The current treatment is thehematopoietic stem cell
transplantation if suitable donors can be found. A gene therapy trial was started in two
patients for whom no donors could be found: therefore autologous CD34+ cells were
transducedexvivoand injectedback intopatients.Thetreatmentresulted in terminationof




chain of hemoglobin is impaired, were reported by Philippe Leboulch and colleagues
(CavazzanaCalvoetal.,2010).Theinitialcasereportfromasinglepatientdemonstratedthe
efficacyofthetherapeuticsprocedure.Insteadofmonthlybloodtransfusions,thepatienthad









target of lentiviral vector transduction. For example, CNSrelated preclinical studies have








2.5 PROTEIN TRANSDUCTION AND LENTIVIRUSES 
Protein transduction refers to the technologieswhereproteins aredelivered to the cells. In
comparison to gene therapy,whereproduction of a protein of interest is dependent on its
translation and in most cases on its transcription, protein transduction aims to directly
introducethefinalproductinthecell,bypassingallgeneregulatorysteps(Fordetal.,2001).
Inadditiontoitsuseasatoolforresearch,proteintransductioncanbeusedinavarietyof









the cell. Most of the techniques utilized for protein transport into the cytoplasm have
similarities with those used in nonviral gene transfer e.g. polymer and liposomebased
approaches. In addition innovativephysicalmethods, such as the combinationof electrical
pulseandcentrifugalforcehavebeenused(Kimetal.,1991).Inmanycases,transfercanbe
promoted by the use of polypeptides or protein transduction domains (PTDs). PTDs are
fused to theproteinof interest to facilitate the receptorindependent cell entry.Atpresent,




basedone.g. leadersequencesof secretedgrowth factorsorcytokines.3.Celltypespecific
peptidesfoundasaresultofhighthroughputscreening(ZahidandRobbins,2012).ThePTD
mediated transport isnotdependenton thesizeof thecargoprotein. In fact, thecargocan
also be nonorganic, e.g. iron beads (Josephson et al., 1999). As a result of mainly
macropinocytosismediatedprotein transductionusingPTDs, the transportedproteinsmay
be unable to leave the endosomes. In order to overcome this obstacle, cationic lipids











in the transport process (Voelkel et al., 2010). Furthermore,with viral vectors, specific cell
populations can also be targeted. The first packaging experiments using retroviruseswere
published in 1990 (Jones et al., 1990;Weldon et al., 1990). These proofofprinciple studies
reliedonthedirectGagfusionswithgalorS.cerevisiaecytochromec,respectively.
One of themost frequentways of introducing foreignproteins into lentiviral particles has
beentheuseoftheVprmediatedtranspackagingmethod(Wuetal.,1995;Satoetal.,1995),
in which the cDNA coding for the endogenous protein is fused with the vpr gene in a
separateplasmid.ExpressedVprfusionproteinsbecomepackaged into thevectorparticles
throughtheir interactionwithp6protein likewildtypeVprs (Paxtonetal.,1993;Kondoet
al.,1995).Wu,Satoandtheircolleaguespackedbacterialstaphylococcalnuclease(SN)and/or
chloramphenicolacetyltransferase intoHIV1derivedvectors todemonstrate the feasibility
oftheapproachwithoutdirectexperimentaltherapeuticapplications,althoughantiviraluse
for SN was considered as a possibility. In 2006, HIV1 based Vprmediated protein
transductionoflinamarasewasreportedasapotentialtreatmentagainstmalignanttumours
(Linketal.,2006).Theenzymelinamaraseconvertstheotherwiseharmlessprodruglimarin
into gaseous cyanide through hydrolysis and it possesses an efficient bystander effect.
Despiteitswideuse,thereareseveraldisadvantagesassociatedwiththeVprsystem.When
usedinthecontextof3rdgenerationLVVs,itrequirestheadditionofafifthplasmidintothe






producer cell)*. In addition to Vprinduced cytotoxicity (Moon and Joosung Yang 2006),
transpackagingalsosuffersfromnonspecificandincompleteproteolyticprocessing,leading
tononprocessedfusionsaswellasprematurecleavagewhichmayreleasethecargoprotein







Vprmediated packaging, these had not been considered for therapeutic purposes outside
targeted integration approaches. In 2010, a report was published describing novel protein
packaging method for gammaretroviruses (Voelkel et al., 2010). This method relied on
incorporating foreign proteins intoGag orGagPol proteins and it could be also used for
DNAtransport.

2.6 SAFETY AND ETHICS OF RETRO- AND LENTIVIRAL GENE TRANSFER 
In the very first years of the 21st century an important step forward in gene therapywas
reported: Xlinked severe combined immunodeficiency (SCIDX1) was corrected in 11
patients by ex vivo common interleukin receptor chain gene transfer usingMLV as the
vector(CavazzanaCalvo,2000).Anotherstudybasedonasimilarstrategywasconductedin
fourpatientsbythegroupofAdrianTrasher(Gasparetal.,2004).InSCIDX1,thefaulty
chain genedisrupts thedevelopment of Tlymphocytes andnaturalkiller cells, and it also
impairsthefunctionofBlymphocytes.Ifnohumanleukocyteantigen(HLA)matcheddonor
isavailable, thediseaseisassociatedwithseriousinfectionsandprematuremortality.After
the apparently successful therapies, the patients started to develop cases of leukemia
resultingfromthetransgeneintegrationandtheactivationofcellulargenesduetotheeffects












When considering gene therapy involving a number of transgene integrations, and a non
specific mechanism of target selection, it is relatively easy to estimate that a certain
percentage of transgenes are going to integrate into 1) an areawithworking cellular gene








leading to its disruption, 2) upstream of a silent gene leading to its activation, or 3) in a
position where foreign sequences (insulators, etc) lead to shutdown of endogenous gene
expression.Theserepresent themainformsof insertionalmutagenesis. In fact, theoretically
thetransgeneintegrationitself,nomatterwhere it is insertedintothegenome, isa formof
mutation. In order to be able to estimate the risks associated with certain therapies, the





integration siteprofile.However, there isnoelement in lentiviral integrationwhichwould
prevent the insertional mutagenesis. When integration sites from the first reported gene
therapytrialusinglentiviralvectorwerestudied,noclonalgrowthorincreasedamountsof
integrationsnearprotooncogeneswerecouldbedetected (EscorsandBreckpot,2010). It is
alsonoteworthy that there are numerousHIVpositive individualswith a largenumber of
lentiviralintegrationsintheircells,whosehealthstatusisnearlynormalaslongastheyare
receiving effective antiretroviralmedication –HIV integration as such is not recognized as
beingacauseofoncogenesisinhumans(Manillaetal.,2005).
Whenitcomestotheethicalpointsofgenetherapy,itstarget,theDNA,isoftenviewedas
the blueprint of life, and therefore any therapy altering it raises strong opinions. Gene
therapymayalsoremindpeopleofthesaderaofeugenics(Wolpert,2005).Thepublicdebate




Sade and Khushf, 1998). When assessing the ethical issues of any current gene therapy
application,twoaspectsneedtobeborneinmind:First,currentgenetherapystudiesaimfor
the correction of severe diseases usually for which there is no readily available effective
treatment, rather than improving the attributesofhealthy individuals. Second,mostof the
studied treatments are aimed at somatic cells while germline effects are unwanted and
extremelyunlikely(Connolly,2002)aswellasbeingprohibitedbylawinmostcountries(Jin
et al., 2008). When somatic gene therapy for serious diseases is considered, there is less
opposition than with germline treatments. If gene therapy is seen as a continuation to
standardmedical care it is notdifficult to justify thedesire to treat theunderlyinggenetic
deficiencyofasanalternativetotreatingthesymptoms.
As current gene therapy refersmainly to clinical trials, the cornerstone concerning ethical
decisionmakingis theDeclarationofHelsinki.This isa“statementofethicalprinciplesfor
medical research involving human subjects” originally composed by World Medical
Association(WMA)in1964.Thecurrentversionhasundergonesixrevisions(WMA,2008).
ThedeclarationofHelsinki ensures the rights of individualpatients andalsoobligates the
physician toprotect their rights aswell as theirhealth.On the otherhand, thedeclaration
recognizesthevalueofresearchinmedicalprogress,which“ultimatelymustincludestudies
involving human subjects”. Despite certain problems associated with the Declaration






Risks are associated with every demandingmedical intervention, and gene therapy is no
exception.Thishasledtospeculationonwhetherthegenetherapyfieldistooafraidofnew
failures – thereforedelaying the availability ofpotential treatments, and this could alsobe
considered unethical (Deakin et al., 2009). The key inmodern translationalmedicine is to
understandtherisksbasedonpreclinicaldataandtoprovidethevoluntarypatientswiththe
necessarybackground informationand risk assessment so they cangive informed consent.
Risksas suchneed tobebalancedalsoagainst thealternativeoutcomeof thedisease ifno




least by their early twenties. It is clear that SCIDX1 patients are not eligible to give their
informedconsentonthetreatmentbecauseoftheiryoungage,andthedecisionontakingthe
risk is up to their legal guardians. In LCA trials, the treatments are initiated only when














The general objective of this thesis was to investigate vector modifications to open novel
approaches for lentiviral vector use. The protein on which interest was focused and the
subjectoftheengineeringwasthelentiviralintegrase,whichhasacentralroleinthevirallife





fusion protein incorporation into 3rd generation lentiviral vectors. More specifically, to
constructINfusionproteinsandtostudytheirincorporationintoproducedlentiviralvector
particlesaswellastheirdeliveryintotargetcells.TouseINmCherryandantitumourINp53




integrase protein into predetermined sites in the genome. To achieve ribosomal DNA 









In the experiments not included in the manuscripts, the aim was to perform an initial
comparisonintothepatternof INwtchromatininteractionagainstthevector integrationsite
data available in the literature. Themain questionswere:what kind of differences, if any,












During thework presented in this thesis, several packaging and transgene plasmidswere
created,andlargenumbersofvectorswereproduced.Inaddition,awidearrayofmethods




4.1 DESCRIPTION OF IN FUSION PARTNERS 







induces apoptosis both as a transcription factor and through transcriptionindependent
pathways and can suppress oncogenic transformation. p53 is active when it exists in a










1999; Boisvert et al., 2007). In addition to numerous rDNA sites, eight fulllength IPpoI
recognitionsitesweremappedintothehumangenomeduringthisstudy.

4.2 DNA MANIPULATION AND MOLECULAR BIOLOGY 
4.2.1Plasmidconstruction(I,II,III)
Construction of pMDLg/pRREINmCherry, pMDLg/pRREINp53 and pMDLg/pRREINI
PpoIwereaccomplishedbyinsertingthecDNAcodingformCherry,p53orIPpoIintoHIV1
IN cDNACterminal end in pBluescriptII SKM (Stratagene/Agilent Technologies) plasmid,
after which the INfusion cDNAwas further transferred into the pMDLg/pRRE lentivirus
vectorpackagingconstructtoreplacemostofitsoriginalINsequence.

The construction of inactive IN containing pMDLg/pRREIND64V and the mutant
meganuclease fusion pMDLg/pRREINIPpoIH78A were accomplished using PCRbased
mutagenesisQuikChange®kits fromStratagene. In the selectionof the transduced cells in
the plasmid rescue integration site analysis assay, a pLVGFPKNR transfer plasmid was






the INmCherry from the pBluescriptII SKMINmCherry and inserting it into pcDNA3.1+
(Invitrogen).Tocreateexpressionplasmid forHistagged INIPpoI,GATEWAY™Cloning
Technology (Gibco BRL, Life Technologies) was applied. The pBluescriptII SKM target
plasmid containing IPpoI recognition sequence was produced by inserting the target
sequence into the EcoRV site in pBluescriptII SKM. Cloning and mutagenesis procedures




Table 4.  Plasmids constructed for the experiments in manuscripts I-III. 
 
Plasmid Produced fusion IN Reference 
pMDLg/pRRE-INmCherry Fluorescent mCherry fused to LVV IN I 
pMDLg/pRRE-INp53 Tumor suppressor p53 fused to LVV IN I 
pMDLg/pRRE-IN-I-PpoI Meganuclease I-PpoI fused to LVV IN II 
pMDLg/pRRE-IN-I-PpoIH78A Mutant I-PpoI with reduced (0.48-fold) catalytic activity III 
pMDLg/pRRE-IN-I-PpoIN119A Mutant I-PpoI without catalytic activity (does not induce 
DSBs. Note: IN is not altered and retains its activity) 
II 
pMDLg/pRRE-IND64V Inactive IN I 
pLV1-GFP-KNR Transgene cassette containing GFP and kana/neomycin 
resistance genes 
I 
pcDNA3.1(+)-IN-mCherry Expression plasmid containing mCherry I 
pBVboostFG-IN-I-PpoI Expression plasmid for His-tagged IN-I-PpoI II 
pBVboostFG-IN Expression plasmid for His-tagged INwt II 
pBluescriptIISKM-I-PpoIsite pBluescriptII SKM containing I-PpoI recognition sequence II 

3.2.2Plasmidrescue(I)
Plasmid rescueanalysiswasperformed inorder to confirm the INmCherry fusionprotein
mediatedgenomicintegrationofatransgeneintothehostcellgenome.Cellswereseededon
the day before transduction with LVV INmCherry GFPKNR or INwt GFPKNR control.
After the transduction,G418 (InvivoGen,SanDiego,USA)wasaddedto theculturemedia
for selection of transgene containing cells. Genomic DNA (gDNA) was extracted and
digestedwith restriction enzymesApaI, BstXI, or EcoRI. Pieces of DNAwere ligated into
circular forms, which were transported into bacteria by electroporation. By antibiotic
selection, only bacteria with the circular transgene were grown for DNA extraction. The























contain any genetic material) were produced using the CaPO4 transfection method on
adherent cells. Cells were transfected with the transfection mix containing four or five
plasmids: Packaging plasmid(s) (pMDLg/pRRE or its derivatives from table 4), transfer
construct (pLV1GFP or its derivatives from table 4), pCMVVSVG and pRSVRev. The
transferplasmidwasnotusedinVLPproduction.Theculturemediawaschangedontheday
posttransfection and vectors were collected 48 hours posttransfection. Crude vector







Reagent Program. The used antiRFP (MBL Medical & Biological Laboratories, Japan)
recognizes also RFP derivative mCherry fluorescent proteins. Furthermore titers were
determined from produced vectors. The p24 titer was determined with a commercial
enzymelinked immunosorbent assay (PerkinElmer Life and Analytical Sciences). The
functionaltiterwasmeasuredonlywhenthetransgenecontainedGFPfluorescentmarker.In
thefunctionaltiterdetermination,HeLacellsweretransducedon6wellplateswithdilution
series using the produced vector. About three days (68 hours) posttransduction, the GFP









Table 5.  LVVs and VLPs produced during the work. GFP is the standard transgene used in the 
produced vectors and generally only transgenes other than GFP are mentioned in the text. 
 
LVV Packaging plasmid TG plasmid Reference 
INwt pMDLg/pRRE pLV1-GFP I, II, III 
INwt GFP-KNR pMDLg/pRRE pLV1-GFP-KNR I 
INwt TK pMDLg/pRRE pLV1-TK III 
VLP INwt pMDLg/pRRE - I 
IND64V pMDLg/pRRE-IND64V pLV1-GFP I 
IND64V GFP-KNR pMDLg/pRRE-IND64V pLV1-GFP-KNR  
IN-mCherry  pMDLg/pRRE-IN-mCherry pLV1-GFP I 
IN-mCherry GFP-KNR pMDLg/pRRE-IN-mCherry pLV1-GFP-KNR I 
VLP IN-mCherry pMDLg/pRRE-IN-mCherry - I 
IN-p53 pMDLg/pRRE-IN-P53 pLV1-GFP I 
IN-p53 GFP-KNR pMDLg/pRRE-IN-P53 pLV1-GFP-KNR I 
VLP IN-p53 pMDLg/pRRE-IN-P53 - I 
IN-I-PpoI pMDLg/pRRE-IN-I-PpoI pLV1-GFP II, III 
VLP IN-I-PpoI pMDLg/pRRE-IN-I-PpoI - II 
IN-I-PpoIH78A pMDLg/pRRE-IN-I-PpoIH78A pLV1-GFP III 
IN-I-PpoIN119A pMDLg/pRRE-IN-I-PpoIN119A pLV1-GFP II 
INwt+IN-I-PpoI pMDLg/pRRE + pMDLg/pRRE-
IN-I-PpoI 
pLV1-GFP II 
INwt+IN-I-PpoIH78A pMDLg/pRRE + pMDLg/pRRE-
IN-I-PpoIH78A 
pLV1-GFP III 
IND64V+IN-I-PpoIH78A pMDLg/pRRE-IND64V + 
pMDLg/pRRE-IN-I-PpoIH78A 
pLV1-GFP III 
INwt+IN-I-PpoIN119A pMDLg/pRRE + pMDLg/pRRE-
IN-I-PpoIN119A 
pLV1-GFP II 


















Table 6.  Cells used in the studies. Medium composition and culture details are described in the 
manuscripts. All lines are human derived with the exception of BT4C rat glioma cells. 
 
Cells Description/origin of cells Reference 
HEK293 Embryonic kidney I 
293T Embryonic kidney cells with large T- antigen I, II, III 
HeLa Cervical cancer I, II, III 
MRC-5 Normal lung fibroblast II, III 
HUVEC Normal primary human umbilical vein endothelial cells I, III 
A549 Epithelial lung carcinoma III 
ARPE-19 Normal retinal pigment epithelia cell line III 
BT4C Rat glioma III 
HepG2 Hepatocellular carcinoma III 
U-87 Glioblastoma astrocytoma III 
U-251 Glioblastoma astrocytoma III 























4.4 HIGH-THROUGHPUT SEQUENCING AND ChIP-ASSAYS 
4.4.1Highthroughputsequencing(II)
Inthe largescaleanalysisof integrationsites,MRC5cellsweretransducedwithLVVsand
cultured for 714 days. gDNA was extracted and digested with restriction enzymes. The
linkerswere ligatedto theDNAendsandtworoundsof ligationmediatedPCR(LMPCR)
was performed. The secondary barcoded product was purified and sequenced with next
generation sequencing (454 Life Sciences GS FLX Titanium pyrosequencing platform,
BeckmanCoulterGenomics,UnitedStates).Thepairedendreadsweredividedintoseparate




By using ChIP based techniques, the contacts (interactions) between a target protein and
DNAcanbestudied.InthefirstChIPexperiment,theinteractionsbetweenINandaspecific




After 6.58 hours of incubation, the cells were crosslinked with 1% formaldehyde for 15
minutes.Crosslinkingwas stoppedwith125mMglycine.Cellswere lysedandDNAwas
sheared into ~500 bp fragments by sonication. The sampleswere preclearedwith salmon
sperm DNA(ssDNA)/Protein A agarose slurry, after which the immunocomplexes were
collectedusinganantibodyagainstIN(AIDSResearchandReferenceReagentProgram)and




In ChIPsequencing, a sequencing library was prepared from ChIPsamples by inserting
sequencingbarcodes intoDNAstrandsandpoolingthesamples.Librarysizewasadjusted
by gel extraction before sequencing. Library was sequenced using Solexa technology
(Illumina)attheEMBLGeneCoregenomicscorefacilityatHeidelberg,Germany.Sequences
were trimmed according toGalaxy FastQC 0.51 (Giardine et al., 2005; Goecks et al., 2010;
Blankenberg et al., 2010) results and aligned to the latest Human genomic assembly
GRCh37/hg19 (Feb. 2009) using Bowtie 1.1.2 tool. Unique genomic coordinates were
compensated for the 3´ end trimming and analyzed for the overlap with target features.
Resultswere analyzed using theGalaxy platform.Custom track visualization andmanual
annotationwas done using the UCSC genome browser (Kent et al., 2002) and its tools at
http://genome.ucsc.edu/. The Quickmap tool (Appelt et al., 2009) was used for largescale
annotation of INwtchromatin interactions. In the subsequent studies of the INwtchromatin
interaction and its comparison to integration pattern, genomic coordinateswere annotated
usingthemotifdiscoveryandnextgenerationsequencinganalysissoftwareHOMER(Heinz
et al., 2010). From the resulting spreadsheets interactions and integrations with genomic
elements were counted using Microsoft Excel and Graph Pad Prism softwares. Also the
bioinformatictoolsGPATandthoseincludedintheEnsembl(http://www.ensembl.org)and
UCSCgenomebrowserswere used.Datawas handled andmanipulated using theGalaxy
platform. The control dataset containing 1×106 randomgenomic sites for the chromosomal








4.5 IN VIVO STUDY (III) 
The effect of LVVmediated IPpoI protein transduction was studied in a subcutaneous
tumourmodel innudemice.A549 cellsweregrownon15 cmplates, and1×106 cellswere
injectedinbothflanksofmaleRPMInudemice(n=26)fromTaconicFarmsInc.Twoweeks
after the injection, suitable tumours were chosen for the experiment. Tumours were
randomizedbetweengroups so thatonlyone typeofvectorwouldbe injectedpermouse.
Only one tumourwas injected if the other one did not fulfill the suitability criteria set in














(Fermentas), hyaluronidase/collagenase and dispase (STEMCELL technologies SARL). The
fraction of proliferating cells was analyzed with immunohistochemical techniques using





All statistical analyses were performed using GraphPad Prism version 5.01 forWindows,
GraphPadSoftware(www.graphpad.com).Generally intheapoptosisandcytoxicityassays
andtitercomparisons,onewayanalysisofvariance(ANOVAs)withDunnett’sandTukey’s
multiple comparison post tests were used. In study III, unpaired t test with Welchs




6 are the same as used by Brady et al. (2009). ChIP data was analyzed using oneway
ANOVAandBonferronisMultipleComparisonTest.StatisticalanalysisforKi67positiveand
GFP expressing cells in dissociated tumour samples were made with oneway ANOVA
combined with Bonferronis and Tukey’s multiple comparisons tests, respectively. Blood
sample datawas analyzedwith twowayANOVA and Bonferronismultiple comparisons












5.1 PRODUCTION OF VIRAL VECTORS USING DIRECT CIS-PACKAGING 
METHOD (I & III) 
Thepackagingstrategyrequiredforthefollowingexperimentswascreatedinthefirststudy
(I).Thestrategywasnamedcispackaging(whiletheVprmediatedmethodofheterologous
protein incorporation is called transpackaging). Several LVVs and VLPs (Table 5) were
successfullyproducedinadherent293TcellsusingCaPO4transfection.IncorporationofIN
mCherry, INp53 and INIPpoI (and its mutants) into the virions was confirmed by
immunoblottingwith antibodies against IN,RT,Gag,RFP andp53 (I/Figure 2, II/Figure I,
III/FigureS1).SomedegradationproductswerevisibleinINmCherryandp53lanes.Incase
ofmCherry this behaviorhasbeendocumented as being related toboilingduring sodium
dodecylsulfate–polyacrylamidegelelectrophoresis (SDS–PAGE)samplepreparation(Gross
et al., 2000).Degradationproductswere seen also in theLVV INp53 lane, but thepattern





was constant and particle titers were generally not affected by the fusion partner. INp53
exhibitedmoderatelydecreasedp24titervalueswhencomparedtoLVVINwtcontrol.





fusionIN induced transgene expression in the functional titer assay, albeitwith a reduced
gene transfer efficiencyas compared toLVV INwt control.Furthermore, theadditionof the
KNRelementintoGFPcassetteslightlydecreasedfunctionaltitervalues.Areductionintiters













Figure 12.  LVV titers reported in manuscripts I and III. FACS titer, transduction units (TUs) per 
ml, is based on the expression of the GFP transgene in transduced cells. p24, particle titer, is the 
amount of p24 protein in the viral preparation and the p24 value correlates with the LVV particle 
number. A and C show p24 titers from study I and III, respectively. B and D show functional titers 
for study I and III, respectively. In study I, one-way ANOVA and Dunnet’s multiple comparion test 
results were used. For study III, unpaired t test with Welch's correction of p24 titer were 
performed to compare INwt and IN-I-PpoI values, since multiple values were available only for 2 






5.2 STUDIES ON mCherry AND p53 PROTEIN TRANSDUCTION (I) 

INmCherry and INp53 fusion protein containing vectors were produced in order to
demonstrate that the novel protein transduction method could be used in experimental
applications. The ability of mCherry to retain its fluorescence when fused to IN was
confirmedfirstbyexpressing it inbacteriaand then ineukaryotic293Tcells (Figure13).A
strong fluorescent signalwas clearlyobservable throughout the 293T cells.The strengthof
fluorescencewaslargelycomparabletotheamountofGFPexpression.

Figure 13. Expression of IN-mCherry fusion protein in bacteria (left) and in 293T cells (right). 
Negative and positive GFP controls are shown in the middle. Brightfield images are shown on the 
first row and red fluorescence on the lower one.

Since thevirionrepresentsadifferentenvironment for the fluorescentproteincompared to
cell cytoplasm, it was desirable to study the fluorescence of LVV INmCherry vector
preparations.InordertodetermineifINmCherrywasfluorescentinsidethevirion,theVLP
INmCherry preparation was adhered to glass coverslips and examined using
immunofluorescenceandconfocalmicroscopy.Atfirstwedemonstratedthefluorescenceof
unstained INmCherry as part of the virion (I/Figure 7a). As a result, fluorescent spots
comparable in size*with 100 nmdiameter fluorescentmicrospheres (I/Figure 7b) could be
visualized. To ensure that the fluorescence originated from the virions, the viral structural
proteinp24wasstainedandimaged(I/Figure7c).Thep24signalwasoverlappingwiththe
signal from INmCherry (I/Figure 7c), which indicated they originated from the same
particle.Thecapability tovisualize intracellularLVV INmCherryvectorparticleswasalso
studiedinHUVECcellsfixed6hoursafterthetransductionwithLVVINmCherry(I/Figure
7hl). INmCherry containing PICs were detected mainly in the cytoplasm, but a small
amount of PICs were also seen in the nucleus. In the intracellular environment, the




line. It is known that wildtype p53 is expressed in HeLa cells, but it is directed for
degradation due toHPV E6 protein (Scheffner andWhitaker 2003). In order to study the

* The practical resolution limit of traditional light microscopes is in a range of 250300 nm, and therefore no absolute
determinationispossibleforthesizeoroverlapinthescaleofvirions(Weiss,2000).






Caspases 3 and 7, which are general markers of apoptosis (reviewed by Lamkanfi and
Kanneganti 2010). INp53 clearly induced the apoptosis in the assay at 48 and 72 hours
timepoints (I/Figure 4). There was also a considerable difference between induction of
apoptosiswithLVVp53andVLPp53withthelatterforminducingapoptosisat72hoursas





be seen by the high inital expression levels with the vector containing IND64V inactive
integrase.Trueintegrationeventswereconfirmedintwoexperiments;longtermexpression
FACSanalysisandintegrationsiteretrieval. InthelongtermFACSstudy(I/Figure6),LVV












bacteria under kanamycin selection. Due to the selectable transgene, each clone could be
furtherenrichedandfinallytheprovirusandtheflankingDNAweresequenced.Duringthe
study, a lownumber of integration sites for LVV INmCherry (n=9) and control LVV INwt
(n=3) with GFPKNR transgenes were sequenced. When the sequences were analyzed
(I/Figure 5), LVV INmCherry integration sites revealed the correct 3’ end processing as
indicatedby themissingCAdinucleotideat the3’LTRend(theCAdinucleotideobserved








5.3 IN-I-Ppo-I AND TARGETED INTEGRATION (II) 
Itwasbelievedthatthecispackagingwasasuitablemethodforuseintargetedintegration
strategies relying on INfusion proteins. To test this hypothesis (Figure 14) a fusion of IN
with IPpoI, a sequencespecificmeganucleaseproteinwas constructed. Its ability todirect













Figure 14. An overview of the targeted vector production and integration mechanism. (1) 
Producer cells are transfected with four producer plasmids, initiating the LVV production. (2) 
Target cells are transduced using the LVVs. (3) Inside target cell nucleus PIC is bound to the 
chromatin containing the I-PpoI recognition sequence and IN catalyzes the transgene joining,  
which leads to (4) the transgene becoming a permanent part of the host cell genome. 

5.3.1Characterizationofcleavageandintegrationactivity
Before initiationof the integrationsitestudies, thecleavagespecificityofrecombinantINI
PpoIfusionwasconfirmedinaplasmidassay(II/FigS1). INIPpoIexhibitedspecificDNA
cleavage of the plasmid containing its recognition sequence. Next it was decided to
determine whether the cleavage specificity would be also present when INIPpoI is
delivered into the cells using LVVs. A large number of IPpoI recognition sequences are
localizedwithinrDNA(Monnatetal.,1999).TherDNA,whichformsthenucleolus,canbe
efficiently immunostained using an antibody to the nucleolusmarker fibrillarin. Genomic
DSBscanbevisualizedbyusingtheH2A.Xantibody(Rogakouetal.,1998).Advantagewas
takenoftheseantibodiesandMRC5cellsweretransducedwithLVVsandVLPscontaining
INIPpoI. The rDNA containing areas (antifibrillarin) andDSBs could be visualizedwith
immunofluorescent techniques. After transduction with LVV INwt, DSB signals were seen
spread throughout the nuclei, and no colocalization with nucleolar areas were observed.
TheseDSBswereprobablycausedby the INactivity (hostcellmachineryrepairs theDNA
strandaftertheintergration,see2.3.2),sincenoDSBswereobservedinnontreatedcontrols.
ApartialcolocalizationofrDNAmarker fibrillarinwithan intenseandconcentratedsignal
from the DSB marker H2A.X was detected after LVV and VLP INIPpoI transduction
(II/Figures3andS2).Thissuggested that INIPpoIwascapableof targetedcleavagewhen
deliveredintocellsusingvectors.SomeDSBsignalswerealsoseenoutsideofthetargetarea.
This may be evidence of cleavage of nonrDNA associated target sites in the genome.
Changes in thenucleolusstructure (II/FigureS2andTableS1)werealsoseenasaresultof
LVVorVLPINIPpoItreatment.Atypicalchangewastheformationofringlikenucleoli.A
similardegreeof cytotoxicitywasobservedwhenvectors containingactive INIPpoIwere










with the new IN fusion partners (Figure 15). This time, in contrast to study I, vectors
containingonly fusion INappeared incapableof inducing longtermtransgeneexpression*.
When INwt or inactive IND64V were added to the production plasmid mix, the integration
efficiencywasrestored.

Figure 15.  Integration efficiencies of different fusion protein containing the vectors deviced in 
study II. GFP-expression is shown as the relative value of day 2 peak expression, when the GFP 
expression is usually at its peak. Expression levels after day 10, when the signal from LVV IND64V-
tranduced cells has faded correspond to actual integration efficiency.

5.3.2IntegrationsitesofLVVINIPpoIN119AcontainingLVVs
The ability to direct transgenes into safe genomic sites for transgene expression without
cytotoxicpotentialwouldbeofgreatvalueingenetherapy.Inordertostudytheintegration
patternofLVVcontainingsequencespecific IPpoI fusedto lentiviral IN, itwasdecidedto
conductahighthroughputsequencingongenomicDNAfromtransducedcells.Thechoice
of fusionproteinwas the noncleaving INIPpoIN119A,whichwas packaged into the vector















the rDNA areas, which we believe could serve as a safe genomic target for transgene
integration in gene therapy. Since the current version of human genome chromosomal
sequencesdoesnot include rDNAsites, integrations into rDNAcontaining separate contig








INwt+INIPpoIN119AdidnotexhibitanyrDNAtargetingover the levelof controlvectors. In
additiontotherDNA,atleasteightIPpoIsiteswerefoundelsewhereinthegenome(II/Table










Figure 16.  Transegene integrations into the rDNA target area. Percentages of rDNA hits of all 
integrations are shown. INwt control A is a small scale (n=480) control set processed with the 
same restriction enzyme as used in the present experimental procedure (restriction enzymes are 
used to cleave gDNA during sequencing sample preparation). Large pyrosequencing data set INwt 






To study the integration site distribution of themodified vectors in general, several other
genomewideparameterswere also examined at (II/TableI). The integration frequency into
GpC islands and GCrich sites was increased in the fusion protein containing vectors as




In summary, the results indicate that integration targeting using INfusion proteins for



































Figure 17. Viability values (mean±SD) as measured by ATP-content in different cell lines after the 
LVV IN-I-PpoI transduction with (A) 2 ng or (B) 10 ng p24 dose (more cell lines analyzed in 
II//Figure S3). Results are shown as relative viability compared to LVV INwt transduced cells. Four 
solid bars for each vector represent the viabilities on days 1, 2, 3 and 6 post transduction (from 
left to right). Statistical significances of viability decrease against LVV INwt control vector are 
shown on top of the bars. Significances from multiple comparison between the cells are shown in 
the tables. The results are analyzed with two-way ANOVA combined with Dunnett’s (against LVV 












aminor growthwas observed until day 13, afterwhich the tumor size started to increase
rapidly,but tumoursizes in the INIPpoIgroupwerebelowthecontrolsalso fromday13
onwards. In comparison to TK+ganciclovir group, the INIPpoI transduction kept the














































Tukey's multiple comparison test d1 d2 d3 d6
A549 2ng vs. HUVEC 2ng *** *** *** ns
A549 2ng vs. MRC-5 2ng ns ** *** ***
A549 2ng vs. U-87 2ng ** ns ns ns
HUVEC 2ng vs. MRC-5 2ng *** ns ns ***
HUVEC 2ng vs. U-87 2ng ** ** *** *
MRC-5 2ng vs. U-87 2ng ** * *** ***
Tukey's multiple comparison test d1 d2 d3 d6
A549 10 ng vs. HUVEC 10ng *** *** *** ***
A549 10 ng vs. MRC-5 10ng ** *** *** ***
A549 10 ng vs. U-87 10ng ** *** ** **
HUVEC 10ng vs. MRC-5 10ng ns *** ns ***
HUVEC 10ng vs. U-87 10ng * ns *** ***





Figure 18. Tumour volume growth in in vivo study as determined by ATP-content in luminescence-
based viability assay. Subcutaneous tumours were injected with three LVVs and growth was 
measured for 22 days.  The difference between INwt and I-PpoI groups is significant from day 13 
onwards. With LVV INwt+TK treatment, differences against control were seen at days 20 and 22. 
Differences between groups were analyzed by two-way ANOVA and Tukey's multiple comparisons 
test (upper asterisks: I-PpoI vs INwt; lower asterisks: INwt+TK vs. INwt). Group sizes: LVV INwt, n 
= 17; LVV IN-I-PpoI, n = 18; LVV INwt TK, n = 6. 


LVV INIPpoI and LVV INwt vectors were packaged with GFP transgenes in order to
monitortransductionefficiencies.Thereforetheentryofvectorsintothetumourcellscould
be confirmed by dissociating the tumour cells andmeasuring the expression of GFPwith
FACS.Randomlyselectedmiceweresacrificedonday3tohaveanearlytimepointdata in
additiontoday22endpointvalues.Attheendoftheexperiment,tumourswererandomized




integration activity and the apparent cytotoxicity to the transduced cells. The dividing
fraction of the tumour cells was determined using immunohistochemical staining of Ki67










In addition to measuring the degree of cytotoxicity associated with the meganuclease
containingvectors, itwasdecidedtoexaminethepossibilitytomodulateitscytotoxicityby
modification of the INIPpoI fusionwith newH78Apointmutation. It has been reported
thatIPpoIH78Aexhibits48%catalyticactivitywhencomparedtowildtypeprotein(Mannino
etal.,1999).ThenewmutantpermittedabetteradjustmentofratiosbetweenDNAcleavage,
transgene integration and the total amountof transgeneDNAcarried into the cells. In the
studyof their cytotoxicpotential,HeLaandMRC5 cellswere transductedwith INIPpoI,
INIPpoIH78A and INwt containingvectors either as singleIN typeor as amixedmultimers
(LVVINwt+INIPpoIH78AandLVVINwt+INIPpoIH78A).Twodifferent(2and10ngp24)vector
doseswereused.Asexpected,theactiveINIPpoIevokedthegreatestdeclineinviabilities
(III/Figure 4)withHeLa cells being againmore susceptible to the treatment.At thehigher
dose,allfusionINcontainingvectorswerecytotoxic.Whenthelower2ngdosewasusedfor











targets can then be collected using antibodies. The presence of the specific DNAarea is
subsequently examined using PCRmethods. In ChIPsequencing, all interactions between
thechromatinandtheproteinofinterestaremappedbydeepsequencing(Figure19).

Figure 19. An overview of the ChIP-sequencing protocol, which is used to map interactions 





























The question answered with the first ChIP study was simple: Does INIPpoI bind to its
genomic target areas? In this study, the IPpoIH78Amutant containingvectorswereused. It
was shown that in LVV INwt+INIPpoIH78A and LVV IND64V+INIPpoIH78A transduced cells,





numerous interactions between IN and the chromatin could be determined. MRC5 cells
were transducedwith INIPpoI as well asmutans INIPpoIH78A, IND64V+INIPpoIH78A and
INwt+INIPpoIH78A–containingvectors.After thesampleprocessing to theChIPsequencing
protocol,asequencinglibrarywaspreparedfromresultingDNAstrands.Highthroughput






the rDNA repeat, when compared to the nonmodified LVV INwt control. The control
interactionswith rDNAareawere in a level of a randomprobability.Also amoreprecise
localizationofinteractionswithintherDNArepeatcouldbemapped.Themostcommonarea
ofinteractionwithintherDNA(Figure20BandFigure21)forfusionINvectorswasthe28S
RNAgene,which contains the single IPpoI target site. The 28SRNAgene hosted 52% of




rDNA, alsononrDNAgenomic IPpoI target siteswere studied.Apart from INIPpoIH78A,





















Figure 20. ChIP-sequencing results showing IN-chromatin interactions (A) with the rDNA repeat, 
(B) with 28S RNA gene of all rDNA hits and (C) non rDNA I-PpoI target areas with different 
window sizes. n refers to the number of unique interactions aligned with the GRCh37/Hg19  
genome. Result are shown as percentage of total interations (n). Random value is not included in 
statistical analysis and is shown only for illustrative purposes. It represents the theoretical 
probability of (A) a hit into one of the (maximum of ~) 600 copies of 43 kb rDNA repeats, or (B) a 
rDNA hit into 28S RNA gene, or (C) into 15 bp I-PpoI recognition site with ±250 bp, 2.5 kb or 25 
kb window. Statistical significances are calculated using the Chi-square (in A & C) and the Fisher's 
exact test (in B). Statistical analysis are made against wt IN. In A the differences between wt IN 
and all of the IN-I-PpoI-containing groups are significant (P<0.001). The situation is the same in 
B and C (P<0.0001), except for the IN-I-PpoIH78A, which has a P-value of 0.0174 in (B) and zero 












































































Figure 21. IN-chromatin interactions within rDNA repeat (A) and from the first rRNA gene area 
(B). In A: Upper blocks (green and brown) represent areas of rDNA repeat; the 5' external 
transcribed sequence (5' ETS), 18S rRNA gene, 5.8S rRNA gene, internal transcribed spacers 
(ITS1 and ITS2), 28S RNA gene, and intergenic spacer (IGS). A and B: IN-chromatin interactions 
are visualized with vertical lines. INwt data (242 sites) is shown in red (labeled wtIN), and 
combined fusion IN data (1055 sites) is shown as blue. The first 90000 bps do not host mapped 
interactions and are omitted from the figure. Figures are created by writing a custom tracks into 
UCSC genome browser. The ChrUn_gl000220 contains two partial rRNA gene repeats separated 










5.5 FURTHER CHARACTERIZATION OF IN-CHROMATIN INTERACTION 
PATTERN 
There is one obvious question to be asked after the determination of the INwtchromatin
interactionpattern; towhatdegreedothese interactionscorrespondto theLVVintegration
pattern? This question, in terms of nonfusion IN, is related more to basic virus/vector
biologythantovectordevelopment.However,abriefcharacterizationofinteractionspread
was conducted using nonmodified LVV INwt vector interaction data in the analysis. The
interactionsiteswereprimarilycomparedagainstthelargescaleintegrationdatasetbyWang





in some areas the high peaks from one graph aremissing from the other graph. Another
genomescale measure, the chromosomal distribution of the INchromatin interaction was
mostlycorrespondingtothe integrationsitedistributionreportedforHIV1(Mitchelletal.,
2004; Nowrouzi et al., 2006) with especially 16, 17 and the generich chromosome 19*








bit. The intrachromosomal interaction distribution pattern was studied by analyzing
chromosomes as 1×106 bp (1 mbp) slices. Some clear hotspots were identified with a
maximumof0.66%(160hits)ofinteractionspersingle1mbpslice(chromosome10,132133
mbp) whereas the random chance for integrations into the particular area (taking into
account the sequencing coverage) was only 0.03%. If smaller window size is used, the
differencesagainstrandompropabilitygrowdramatically.Duetothetightclusteringofsites
the overall interactiondensity can bedescribedhighly variable,with over 100 interactions
mapped per 500 nucleotide areas in some locations, followed by millions of nucleotides
without any interactions. The same phenomena could be seen when genes with most
interactionhits inside themwere studied:Between121and231 interactionspergenewere
mapped into five most frequently hit genes (RNA58S5, GLRX3, FAM163B, CYTH4 and
KLHL25), whereas a maximum of 63 integration events were mapped into single gene
(KDM2A)when24764randomhitsfromtheintegrationdatasetwerechosenfortheanalysis.
Whenthe20most frequentlyassessedgenomic1mbpslices for interactionand integration
sitedistributionwerecompared,nooverlapwasseenbetweenthesites.

      
      
      










Figure 22. Visualization of IN-chromatin interactions (solid bars) and large-scale integration 
(outlined bars) data (Wang et al., 2007). Visualization is constructed using Ensembl genome 


















Figure 24. Localization of interaction and integration sites in (A) different genomic areas and (B) 
their distance to nearest transcription start site (TSS). TTS: Transcription termination site.

GpG islands are active genomic areas associated with gene promoters. In all, 5.43 % of
studiedinteractionsweremappedintoCpGislands(random0.8%,P<0.001).ForHIVthe















groups. The genes with interactions or integrations were analyzed using the GPAT tool
(Krebsetal.,2008).MRC5geneexpressiondatawasnotavailableforuse,so293Tcelldata
was used instead. Although there are probably considerable differences in the gene
expression levels for single genes when using expression data from another cell line, one
couldpresumethatthegeneexpressioncouldberepresentativeonthelargescale.Themean




Since the properties of the interaction pattern differed from those of the integration site
spread, apossiblebiological functionwasprobedby conductingapreliminary targetgene
characterization:GeneswhicharelinkedtoHIVinfectionorwhoseexpressionisaltereddue
toHIVentryweremanuallysoughtfromtheareas,whereahighdensityofinteractionshad





Table 8. Genes flanking or overlapping with the interaction peaks from areas where the 
interaction:integration ratio is high (see figure 22 for graphical representation of 10 studied 
areas). 
 
Location Symbol Gene Notes 
7q36.3 UBE3C Ubiquitin protein ligase E3C An ubiquitin ligase. Downregulated during 
HIV-1 based vector integration phase 
(Imbeault et al., 2012).  
7q36.3 DNAJB6 DnaJ (Hsp40) homolog, subfamily 
B, member 6 
Upregulated during HIV-1 based vector 
integration phase (Imbeault et al., 2012). 
Important role in Nef-mediated gene 
expression. Nef induces DNAJB6 expression 
in HIV-1 infected cells (Kumar and Mitra, 
2005). Is known to enhance HIV-2 PIC 
nuclear localization. 
8p21.3 SLC39A14 Solute carrier family 39 (zinc 
transporter), member 14 
Upregulated 24 h after the HIV-1 infection. 
(Mohammadi et al., 2013) Prevents 
apoptosis (Duffy et al., 2001). 
10q21.3 DACT1 Dapper, antagonist of beta-
catenin, homolog 1 (Xenopus 
laevis) 
Downregulated 24h after HIV-1 infection 
(Mohammadi et al., 2013). 
In addition to slow and even biasprone manual search, the list of genes containing
interactionswasalsosubjectedtoGeneOntology(GO)termsearchusingthegeneontology
enrichmentanalysisandvisualizationtoolGorilla(Edenetal.,2009).Asaresult,5GOterms
describing cellular processes (e.g. cell differentiation andpositive regulation ofmitotic cell











Table 9. The most significant GO-terms associated with the genes flanking the genomic IN-
interaction sites. 

GO term Description P-value FDR q-value 
GO:0051828 Entry into other organism involved in symbiotic 
interaction 
6.23E-06 4.99E-02 
GO:0051806 Entry into cell of other organism involved in symbiotic 
interaction 
6.23E-06 2.49E-02 
GO:0030260 Entry into host cell 6.23E-06 1.66E-02 
GO:0052192 Movement in environment of other organism involved 
in symbiotic interaction 
6.23E-06 1.25E-02 
GO:0052126 Movement in host environment 6.23E-06 9.97E-03 
GO:0044409 Entry into host 6.23E-06 8.31E-03 
GO:0046718 Viral entry into host cell 4.10E-05 4.69E-02 
    












6.1 PACKAGING OF PROTEINS INTO LVVs AND VLPs  
In this thesis, thedirect cispackagingmethod (Figure25) for foreignprotein incorporation
intolentiviralvectorswascharacterized.Toourknowledge,thisisthefirstexampleofactive
fullsize protein packaging into 3rd generation LVVs via their expression from gagpol.






the large scale. It has beennoted that inVprmediated transpackaging, the cytotoxicity of
packagedproteinaffectstheproducercells(Linketal.,2006),despitefusionwithVpr.Also
Vpralonehasapoptoticandcellcyclearrestingproperties,whicharenotsuppressedwhenit
is fused intoanotherprotein  (Muthumanietal.,2000). Incispackaging, thecargoproteins
are produced as part of the large GagPol polyprotein, and are cleaved only during the
maturationofthevectorparticle.Asshowninthecytotoxicitystudies(III),293Tcellsusedfor
the LVVproduction are susceptible to IPpoI inducedDSBswhen the protein is delivered






Figure 25.  Differences between trans- and cis-packaging and direct fusion strategies for protein 
incorporation into LVVs. dVIF and dNEF are deletion-containing Vif and Nef proteins. In cis-
packaging, the addition of the fifth plasmid into the vector production is not necessary. 
trans-packaging strategy cis-packaging strategy (direct fusion)


























VSV-GCMV polyA pMD2L: Envelope







the protein can form tetrameric structures and be functional despite the bulky IN fusion
partnersandtheirinternal(PIC)andexternal(LEDGF/p75,chromatin)interactions.INisalso
present in itsactive formin thePICasa tetramer (Hareetal.,2010),andalthough there is
only a limited number (20250) of INmolecules present in the vector particle (Briggs and
Simon, 2004;Denard et al., 2009), p53 has amarked effect on target cells. p53was able to
induce apoptosis in HeLa cells very efficiently. However, it is probable that only effector
proteinsactiveinlowconcentrationscanbeefficientlyusedinthedirectpackagingsystem.
mCherry and p53 were shown to be useful tools for research purposes when they were
packagedintoLVVsorVLPs.Usingthecurrentgenetransfertechniques,itstransportintoall
tumourcellsisnotpossible,andduetoitsverylimited,evencontradictory,bystandereffect
(Rizk et al., 1999) it is not necessarily a therapeutic choice when used alone, although a
suitable therapeutic transgenecouldchangethesituation.However,LVVINp53efficiently
demonstrated the ability to induce cellular responses via protein transduction using a
platform towhich therapeutic transgenes can become attached. In apoptosis studies using
p53, an interestingobservationwasmadewhenVLPswere seen to induceapoptosismore
efficientlythanLVVs.Accordingtotheresultsofwesternblotexperiments,thep53content
ofVLPswasnotat leastdramaticallyhigher. It ispossible that thedifferencesweredue to
kinetic effects resulting from the lack of reverse transduction, which may lead to faster
nuclear transfer of theproteins and therefore themaximum temporalp53 concentration in
nucleusmayattainahigherlevel.Thiscouldberathereasilystudiedfromnuclearextractsor
byconfocalmicroscopy.Alternatively the lackof transgenecould lead to the releaseof the
proteins constituting thePIC soonafter thenuclear entry.WhenmCherrywasusedas the
fusionpartner,virionswereobservableassuchandalsointhecytoplasmoftransducedcells.
However,forefficientvisualizationofintracellularvirions,mCherryshouldbereplacedwith
a fluorescentproteinwithahigherquantumyieldandbrightness, suchas themOrangeor
dTomato(Shaneretal.,2004).

Oneof theclearadvantagesof thedirectpackagingmethod is theability to transportboth




targeting.The integrationprofileof transposonsystemsdoesnotpreferactivegenes to the
sameextentasHIV1 (Yantetal.,2005),and it is thereforeconsideredasasafealternative.
Transposition through the use of IDLVs has been demonstrated (Vink et al., 2009) with
separate LVVs to transport expression cassettes formodified transposon and transposase.
Through cispackaging these could be combined into a single vector. Another potential
application is the homologous recombination (HR), which can be enhanced by the use of
DNAcleavingproteins,suchaszincfingers(reviewedbyCarroll,2011).Cispackagingcould
alsobeexploitedinHRstrategiesbycombiningaDNAcleavingproteinandatransgeneinto
a single vector. The third potential application is with the piPSCs (protein induced
pluripotent stem cells) techniques (Zhou et al., 2009), where proteins with carcinogenic









6.2 CYTOTOXICITY ASSOCIATED WITH IN-I-PpoI 
ChromatinDSBsoccurinallcells,butthecellularrepairmechanismsareusuallycapablefor








sensitivity of U87 andU251 cell lines (III/Figure S3), despite the fact thatU87 has been










startsat telophaseand isdirectedbyrRNAgeneclustersand it requires their transcription
for completion (Stevens and Prescott, 1971; Benavente et al., 1987). Ringlike nucleoli are
characterized as resting,whichmeans that there is a low rRNAproduction rate (Smetana,
2002).Thesearefoundinsenescentcells,whichcanbestimulatedtoreturntothenormalcell





transduction in a challenging tumour environment. After treating subcutaneous tumours
withLVVINIPpoIvectors, the tumoursizeremainedsteady for13daysbefore themajor
growthphasebegun.ItispossiblethatinA549tumours,thetreatmentinducedsenescencein
additiontocelldeathandalargeamountofsenescentcellscouldhavebeenmaintainingthe












* Although a bystander effect has not been demonstrated with IPpoI treatment, it is not impossible: An alphaparticle
radiationinducedbystandereffectwasdescribedin1992.Itledtochromosomalchangesin30%ofthecellswhenonly1%
hadbeen irradiated.Theeffecthasbeendemonstratedalsoas response to themedia fromdamagedcells. Thebystander










According to the experiments with LVV INIPpoIH78A and mixed multimer vectors, the
cytotoxicityassociatedwiththeuseofIPpoIcanbedecreasedbyusingmixedmultimersand
H78Amutatedversionof IPpoI. In thisway, the ratio betweendeliveredDNA, transgene
integration and induced DSBs can be adjusted depending on the application. Here two
differenttypesofINwereemployedpervirion,butitwouldpossibletoaddathirdtypeinto
theproductionmixifnecessary.ItshouldbenotedthatH78AandN119AmutationsintheI







6.3 TARGETING OF LVV INTEGRATION 
Transgeneintegrationisnecessaryifonewishestoachievelongtermgeneexpression,which
isaprerequisiteforseveraltherapeuticstrategies.Ontheotherhand,integrationalsoposesa
risk of genotoxic effects. LVVs as such have a lower potential for genotoxicity e.g. when
compared to gammaretroviral vectors. This is mostly due to the integration specificity of
LVVs, which does not favor transcription start sites or cancerrelated genes. Despite the
favorableintegrationsitepatternofLVVs,controloverthespecificityofintegrationwouldbe
of great value to help to predict the transgene behavior and tominimize the risks. Itwas
therefore decided to exploit the DNA recognition specificity of IPpoI for targeting the
integration into rDNA areas (Figure 14). Since DSB induction was not required in this
approach,thenoncatalyticmutantN119AofIPpoIwasusedinthetargetingexperiments.
By using LVV IND64V+INIPpoIN119A vector, a rDNA targeting efficiency of 2.7 % of all
integrations was achieved, while the control data set exhibited only 0.1 % integration
probability into the rDNA area.Despite the low total amount of targeted integrations, the
levelof targetingdemonstratedherewasalready23 foldhigher than thatachievedwitha
comparable strategy attempted elsewhere (Tan et al., 2006). In summary, this proofof
conceptresultopensupseveralpossibilitiesforINmediatedintegrationtargeting.






five acrocentric chromosomes. These genomic areas do not contain protein coding genes,
whichdecreasethepotentialforthemtointerferewithgenefunctionortoactivateunwanted
genes. The large intergenic spacer areas function as insulators between the repeats.
Disruptionofevenseveral rDNAsitesby the transgenewouldprobablynotbeaproblem,










Despite the integration targeting into the rDNA, the targeted vectors described here still
undergothemajorityoftheirintegrationselsewhereinthegenome.Theiroverallintegration
tendencywas for the GpG island containing andGC rich areas,which usually represents
genomic areas with a high density of active genes (GardinerGarden and Frommer, 1987;
Larsenetal.,1992).Intermsoftransgeneexpression,thesearebeneficialtargetareas,butthe





type HIV and control vector behavior, since LEDGF/p75 directs the integration such that
there is an overrepresentation of ATrich sequences close by the integration sites. This is
possiblydue to theAThook structureofLEDGF/p75 (Ciuffi et al., 2005). Interestingly, the
shiftfrompreferringGCrichsequencesovertheATrichonesisseenalsowithnonmodified
LVVs when the LEDGF/p75 is depleted from the cells (Marshall et al., 2007). One of the
theoretical obstacles impeding the fusionIN targeting strategies is the LEDGF/p75, which
tethersviral IN into chromatin. It couldbepossible that theDNAbindingof the targeting
fusion partner could not compete with the LEDGF/p75DNA interaction. However, our
positivetargetingresultscombinedwiththeshiftofintegrationsitedistributiontowardsthe
LEDGF/p75independent direction suggest that the effect of LEDGF/p75 is not so strong
whenthepresenttargetedvectorisused.Thismaybeduetosterichindrances–theIPpoI






Figure 26.  The inner IN subunits and stretches of viral DNA, visualized using Jmol (an open-
source Java viewer for chemical structures in 3D, http://www.jmol.org/) at Research 
Collaboratory for Structural Bioinformatics Protein Data Bank (RCSB PDB) database 
(http://www.rcsb.org/pdb/). PBD ID: 3L2R, based on prototype foamy virus data by Hare et al., 
2010. A shows the CPK model. In B the place of C-terminal fusion and viral DNA are illustrated. C 














IN, which is tethered to the genomic target site using a noncleaving meganuclease for
sequencerecognition.Thetargetingvectorsdescribedhererepresentthe“firstgeneration”of
thesevectors;theirINcontentsorratiosbetweendifferentINsinsidethevectorhavenotyet





transgene into the target area without any subsequent integration and is therefore not
applicable as such. In this case, however, the transgene could be modified to contain
homologousDNAsequences(homologyarms)tothetargetsite,whichwouldthenperhaps
lead to transgene insertion through HR. Thus IN activity is not necessarily the only
mechanism for transgene insertion. Inactive IN is already being used (without targeting
domains) inHRstrategiesandthetetheringofrecombinationsubstrate(thetransgene) into












of thisbinding  (Emilianietal.,2005).Wehaveconstructed INmutants, suchasQ168A, to















6.4 IN-CHROMATIN INTERACTIONS 
InthisstudyChIPsequencingwasusedtomaplentiviralINchromatininteractions(forthe
first time, to our knowledge). It could be confirmed that there were a high amount of
interactionsbetween fusion INand thegenomic target areas. Interactionsmapped into the
28SRNAgenecontainingtheIPpoItargetsequencewereincreasedonaverageby100fold











differencesbetween integrationand interactionpatterns in termsof favoringgenomicsites,
the interaction behavior could be further away from random than that of IN suggesting it
wasnot the lossofspecificityorrandomprocess thataccountedfor thedifferencebetween
interaction and integration. The INchromatin interaction did favor hallmarks of active
genetic areas, such as CpG signals and TSSs. And it also avoided repetitive elements and







the chromatin,perhapsafter theprovirus integration.Mostviruses areunder evolutionary




prevent or downregulate the expression of antiviral genes whose expression could be
otherwisetriggeredbyviralinfectionorenhancetheexpressionofgenesbeneficialforvirus
replication. The chromosomal areas flanking the interaction sites backed this hypothesis.
When GOterms for genes flanking the interactions were analyzed, results included GO
terms associatedwith biological processed such as “entry into other organism involved in
symbiotic interaction”and“viral entry intohost cell”.Bymanualanalysisof 10 sites,with
high number of interactions without an equal rise in integration pattern, 4 genes, whose
expression isalteredafter lentiviralcellentry,were found.Forexample, thepeakobserved
on chromosome 8 parm for LVV INwt interactions is localized into the intron of the zinc
transporter SLC39A14 gene. SLC39A14 is known to be upregulated in HIV1 infection








within the immediate scope of this thesis. It should be also noted that massive gene
expression changes take place during HIV1 infection with initial large scale gene












Vectordevelopment, protein transduction and lentiviral integration targetingwere studied
during this thesis. According to present results, packaging of foreign proteins into LVV
particles can be achieved through the novel cispackagingmethod despite earlier negative
indications.FusionofforeignproteincDNACterminaltoINistoleratedinLVVsandleads
to correct proteolytic processing and packaging of protein cargo. The low amount of






found that integration targeting through the use of INtethering domains is a potential
strategyfordirectingthetransgenesintopredeterminedsitesinthegenome.Integrationsite




The introduction of IPpoI meganuclease into the cells leads to DSB formation. This
phenomenoncouldbeexploitedintargetedintegrationthroughhomologousrecombination.
DSBs induce cytotoxic effects, which are celltype dependent. During the study it was
observedthatcertaincancerouscelllinesareespeciallypronetoDSBsoccurringinrDNAas





ChIPsequencing. In our interaction studies, the INchromatin interaction and integration
distributiondidnotcorrelate inall respects,and insomecases therewasadifference from
the randomvalues.The reason for this is unknown, but onehypothesis is that part of the
interactions takes place after the integration reaction and may be reflecting biologically
functionalprocess,wheretheINaltersthehostcellfunction.

In summary, the results obtained during these studies strengthen the applicability of the























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Publications of the University of Eastern Finland
Dissertations in Health Sciences
isbn 978-952-61-1113-1
Publications of the University of Eastern Finland






























Site Selection and Cellular
Delivery of Heterologous 
Proteins
Vesa Turkki
Lentiviral Integrase-fusions: Genomic 
Interactions, Site Selection and Cellular 
Delivery of Heterologous Proteins
In this study, a protein delivery 
method based on lentiviral 
integrase-fusions was characterized. 
Its applicability was demonstrated 
with a fluorescent marker protein 
to allow virus labeling, a tumour 
suppressor protein and a DNA-
cleaving meganuclease. Modified 
cleavage-deficient meganucleases 
were shown capable of directing 
the integration into genomic target 
areas. Furthermore, the interactions 
between the integrase and the host 
cell genome were mapped for the 
first time. 
